The QualityStocks Daily Tuesday, December 6th, 2022

Today's Top 3 Investment Newsletters

PennyStockProphet(SMMT) $2.3100 +194.27%

MarketClub Analysis(RMED) $5.5500 +33.09%

Tiny Gems(ATDS) $1.0500 +23.53%

The QualityStocks Daily Stock List

Meta Materials (MMAT)

Schaeffer's, QualityStocks, InvestorPlace, MarketClub Analysis and MarketBeat reported earlier on Meta Materials (MMAT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Meta Materials Inc. (NASDAQ: MMAT) is a smart materials and photonics firm that is engaged in the invention, design, development and manufacture of different functional materials and nanocomposites.

The firm has its headquarters in Dartmouth, Canada and was incorporated in 2021, on June 23rd by Themos Kallos and George Palikaras. It operates as part of the materials sector, under the chemicals sub-industry and serves consumers across the globe.

The enterprise specializes in the manufacture of highly functional films that have been engineered at the nanoscale to harness electromagnetic waves and the power of light. Its technology platform comprises of 3 core capabilities, namely wireless sensing, lithography and holography. This allows the enterprise to develop a library of functional prototypes and solutions at lower costs and at a much faster pace than traditional chemical synthesis. The enterprise serves the 5G communications, health and wellness, consumer electronics, clean energy, aerospace and defense and automotive industries across the globe and has sales as well as research and development offices in the Silicon Valley and London.

The company’s sustainable higher performance multi-use products employ the use of lightweight raw materials and processes to provide superior performance and consume less energy. Its products include a holographic optical component known as holoOPTIX; a revolutionary transparent conductive film dubbed NANOWEB; and a laser glare protection eyewear known as metaAIR. In addition to this, the company also develops Glucowise.

The firm recently concluded a project to develop a non-invasive glucose sensing prototype which can accurately predict changes in glucose level in diabetes patient. The prototype eliminates the need to draw blood in order to measure glucose levels. Its success will not only benefit patients with diabetes but also extend the firm’s consumer reach, which will be good for investments.

Meta Materials (MMAT), closed Tuesday's trading session at $1.95, up 14.0351%, on 20,923,697 volume. The average volume for the last 3 months is 310,671 and the stock's 52-week low/high is $0.63/$3.5282.

FLJ Group (FLJ)

We reported earlier on FLJ Group (FLJ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

FLJ Group Ltd (NASDAQ: FLJ) is a holding firm that is focused on providing and operating a long-term apartment rental platform as well as providing other real estate services.

The firm has its headquarters in Shanghai, the People’s Republic of China and was incorporated in 2012 by Guang Jie Jin. Prior to its name change in September 2022, the firm was known as Q&K International Group Ltd. It operates in the real estate sector, under the real estate services sub-industry and serves consumers in China.

The enterprise is strategically focused on sourcing apartments under the lease-and-operate model in locations that are relatively inexpensive, to offer their tenants value for money. It applies technology to each step of its operations, from renovation and apartment sourcing to tenant acquisition. This allows the enterprise to operate a fast-growing portfolio of apartments with high operational efficiency, enabling them to deliver a superior user experience.

The company provides branded apartments as well as facilitates value-added services. It leases apartments from landlords and then renovates them into standardized furnished rooms, which can then be leased to young individuals who seek affordable, ready-to-move-in, conveniently located residences in cities. In addition, it cooperates with 3rd parties, including e-commerce firms and professional home service providers, to provide value-added services to its tenants. The company also offers utility services and internet connection as part of its lease agreements.

The firm, which recently changed its name, is focused on growing organically and is working on acquiring high quality assets. Its management team is also focused on improving the firm’s ability to execute its growth strategy and strengthening the business, which is bound to bring in more investors.

FLJ Group (FLJ), closed Tuesday's trading session at $1.335, up 11.25%, on 310,859 volume. The average volume for the last 3 months is 9,850 and the stock's 52-week low/high is $0.601/$3.87.

Imunon Inc. (IMNN)

We reported earlier on Imunon Inc. (IMNN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Imunon Inc. (NASDAQ: IMNN) (FRA: CBO) (LON: 0HUZ) is a clinical-stage biopharmaceutical firm that is focused on developing and commercializing DNA-based vaccines, immunotherapies and directed chemotherapies.

The firm has its headquarters in Lawreneceville, New Jersey and was incorporated in 1982 by Yim-Pan Cheung. Prior to its name change, the firm was known as Celsion Corp. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers around the globe.

The company is focused on advancing a portfolio of innovative treatments which harness the body's natural mechanisms to generate effective, safe and durable responses across a broad array of human illnesses. It operates through the ThermoDox and Celsion brands.

The enterprise has developed a feasibility stage platform technology for the development of nucleic acid-based vaccines, immunotherapies and other anti-cancer DNA or RNA therapies dubbed TheraPlas; and its Placcine platform, which develops nucleic acid vaccines for cancer and other infectious illnesses. Its product pipeline is comprised of a DNA-based immunotherapy dubbed GEN-1, which has been developed to locally treat ovarian cancer. It also develops a proprietary heat-activated liposomal encapsulation of doxorubicin known as ThermoDox, which is in the development stage for a range of cancer indications.

The company, which recently provided a business update, remains focused on advancing its pipeline, whose success and approval will bring in additional revenues and investments into the firm. This is in addition to benefiting patients with various indications and generating value for its shareholders.

Imunon Inc. (IMNN), closed Tuesday's trading session at $1.47, off by 0.675676%, on 9,850 volume. The average volume for the last 3 months is 55,204 and the stock's 52-week low/high is $1.35/$10.9485.

Fanhua Inc. (FANH)

MarketBeat, StreetInsider, StocksEarning, Zacks, The Online Investor, Money Morning and FreeRealTime reported earlier on Fanhua Inc. (FANH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Fanhua Inc. (NASDAQ: FANH) (FRA: 4CIA) is an independent insurance intermediary firm that is focused on the distribution of insurance products.

The firm has its headquarters in Guangzhou, China and was incorporated in 1998 by Qiu Ping Lau and Yin An Hu. Prior to its name change in December 2016, the firm was known as CNinsure Inc. It operates as part of the insurance brokers industry, under the financial services sector. The firm serves consumers in the People’s Republic of China.

The company operates through the Insurance Agency and Claims Adjusting segments. The Insurance Agency segment offers property and casualty insurance products such as individual accident, homeowner, travel and indemnity medical insurance products; and life insurance products, like individual whole life, individual health, individual term life and individual annuity products. This segment generates most of the company’s revenue. On the other hand, the Claims Adjusting segment provides claims adjusting, pre-underwriting survey, residual value disposal and consulting services. It also operates an all-in-one insurance sales and service platform dubbed Lan Zhanggui; an online insurance platform known as baoxian.com; an online claims services resource aggregating platform dubbed Chetong.net; and an online mutual aid platform known as ehuzhu.com. It serves consumers through insurance agencies, registered independent sales agents and in-house claims adjustors, among others.

The enterprise recently launched its open platform, which is aimed at empowering independent insurance agents and agencies on the market. This move will not only extend the firm’s reach but also open it up to new growth and investment opportunities.

Fanhua Inc. (FANH), closed Tuesday's trading session at $7, up 5.2632%, on 55,378 volume. The average volume for the last 3 months is 28,209 and the stock's 52-week low/high is $4.31/$11.80.

GreenTree Hospitality Group (GHG)

MarketBeat, StocksEarning, Zacks, Trading Concepts, StreetInsider, Market Intelligence Center Alert, Trades Of The Day, TradersPro, StockMarketWatch and Daily Trade Alert reported earlier on GreenTree Hospitality Group (GHG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

GreenTree Hospitality Group Ltd (NYSE: GHG) (FRA: GT1A) is a holding firm that operates as a franchised hotel operator in charge of developing leased-and-operated as well as franchised-and-managed hotels.

The firm has its headquarters in Shanghai, the People’s Republic of China and was incorporated in 2004, on October 18th by Alex S. Xu. It operates as part of the lodging industry, under the consumer cyclical sector. The firm serves the hospital industry around the globe, with a primary focus on consumers in China.

The company is driven by the research and implementation of green initiatives at each hotel, resulting in myriad environmental efforts. It is dedicated to operate mid-scale hotels through its main brand, known as GreenTree Inns. The company operates its business primarily in China and operates as a subsidiary of GreenTree Inns Hotel Management Group Inc.

The enterprise’s portfolio consists of The GreenTree Inn, GreenTree Inn & Suites, GreenTree Hotel, GreenTree Extended Stay, and GreenTree Boutique Collection hotels, which are trusted by leisure and corporate travelers in search of modern, reliable guest rooms and relaxing lounge areas. As of December 2021, it operated sixty-six leased-and-operated hotels with 7,064 rooms; and had a franchised-and-managed hotels network comprising of 4,593 hotels with 330,089 rooms covering 367 cities in China.

The firm remains focused on expanding, having already included mid-to-up-scale and luxury segments in its brand portfolio through a series of strategic investments. This will not only enable the firm to extend its consumer reach but also allow it to create value for its shareholders.

GreenTree Hospitality Group (GHG), closed Tuesday's trading session at $3.57, off by 1.108%, on 28,209 volume. The average volume for the last 3 months is 40,227 and the stock's 52-week low/high is $2.32/$9.1799.

Nexalin Technology (NXL)

We reported earlier on Nexalin Technology (NXL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Nexalin Technology Inc. (NASDAQ: NXL) is a medical device firm that is focused on designing and developing neurostimulation products to help treat mental health conditions.

The firm has its headquarters in Houston, Texas and was incorporated in 2010. It operates as part of the medical devices industry, under the healthcare sector. The firm serves consumers around the globe, with a primary focus on consumers in China and the United States.

The company designs products that are non-invasive and undetectable and can provide relief to patients afflicted with mental health issues, without adverse side effects. It has a patented, frequency-related, advanced waveform that interacts with the deep centers of the midbrain to deliver relief. The designs have varying currents, voltages and electromagnetic fields, as well as various frequencies.

The enterprise has developed a non-invasive and drug-free therapy known as the Nexalin Device (Generation 1 or Gen-1), to help treat insomnia, depression and anxiety. The device stimulates a positive response from the mid-brain structures linked to a range of mental health conditions. It also develops a medical device dubbed Generation 2, which is in clinical trials for the treatment of substance abuse issues related to chronic pain, opiates, dementia and Alzheimer's disease.

The firm recently announced a new publication, which shows that its Nexalin device may help treat some mental illnesses. The success and approval of this device for use in treating the aforementioned indications will not only benefit patients who do not respond to current therapies but also generate additional revenues for the firm.

Nexalin Technology (NXL), closed Tuesday's trading session at $2.2871, off by 3.4979%, on 40,227 volume. The average volume for the last 3 months is 225,994 and the stock's 52-week low/high is $1.04/$3.23.

SoundHound AI (SOUN)

MarketBeat and The Stock Dork reported earlier on SoundHound AI (SOUN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

SoundHound AI Inc. (NASDAQ: SOUN) is a software firm that is focused on developing an independent voice artificial intelligence (AI) platform that enables businesses across industries to deliver conversational experiences to their consumers.

The firm has its headquarters in Santa Clara, California and was incorporated in 2005, on September 2nd. It operates as part of the software-application industry, under the technology sector. The firm serves consumers across the globe.

The company’s vision is to create a voice AI platform that exceeds human capabilities and brings delight as well as value through an ecosystem of billions of products enhanced by innovation and monetization opportunities.

The enterprise’s advanced voice AI platform, dubbed Houndify, is built on proprietary Speech-to-Meaning and Deep Meaning Understanding technologies and offers speed and accuracy while also allowing people to interact with products and services as they interact with each other; by speaking naturally. Through its Deep Meaning Understanding technology, the user's voice assistant addresses multiple questions and filters results simultaneously while its Speech-to-Meaning technology tracks speech in real-time and understands it, even before an individual finishes speaking. Its other products include its SoundHound App, Midomi.com and Hound App.

The company recently entered into an agreement with Harman to deliver effortless voice AI experience to the automotive market. This move not only facilitates the company’s entrance in a new market but will also open it up to new growth and investments opportunities that will in turn, create value for its shareholders.

SoundHound AI (SOUN), closed Tuesday's trading session at $1.29, up 1.5748%, on 226,494 volume. The average volume for the last 3 months is 325,038 and the stock's 52-week low/high is $1.15/$18.14.

Stemtech Corp. (STEK)

We reported earlier on Stemtech Corp. (STEK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Stemtech (OTCQB: STEK), an innovative stemceutical(TM) company and a pioneer in the field of stem cell nutrition, has introduced its new CellectOne(TM) innovative and cutting-edge skincare line; Stemtech also launched the first offering in the product line: the Rapid Renew Stem Cell Peptide Night Cream. Stemtech is partnering with Life Factor Research to create product lines designed to build a dedicated and naturally expanding following. This new product line and initial product offering is the foundation of that strategic plan. “Introducing a new product is always a significant mark of advancement,” said Stemtech Corporation president and COO John W. Meyer in the press release. “This new branding of the Stemtech Corporation stem cell skincare line under brand CellectOne is a great step forward. The strategic vision of Stemtech continues to become reality with the Life Factor Research contributions of new cutting-edge science and technology. We are proud to introduce the first of many new products to come. CellectOne products are developed by Stemtech's new Research and Development Division, Life Factor Research. The science and technology used to create the Rapid Renew Stem Cell Peptide Night Cream is a tremendous, all-natural, ingredient-based product which penetrates deeply into the skin layers for improving skin health.”

To view the full press release, visit https://ibn.fm/2BGNg

About Stemtech Corp.

Stemtech Corporation, a leading stemceutical company with a direct-sales distribution model, was founded on April 18, 2018, after acquiring the operations from its predecessor Stemtech International Inc., which was established in 2005. From 2010 through 2015, Stemtech International Inc. was recognized four times on the Inc. 5000 Fastest-Growing Companies list. In 2018, Stemtech underwent an extensive executive reorganization and continued operations under new leadership as Stemtech Corporation. In August 2021, Stemtech became a publicly traded company and has expanded business opportunities for its independent business partners, who may earn incomes by sharing Stemtech products. The company markets its products under the following brands: RCM System, stemrelease3(TM), Stemflo(R) MigraStem, OraStem(R) (Oral Health Care), CellectOne (skincare products) and D-Fuze(TM) (EMF blocker). Its stemceutical products are all natural, plant based and manufactured under Current Good Manufacturing Practices under the auspices of the Dietary Supplement Health and Education Act. For more information about the company, please visit www.Stemtech.com.

Stemtech Corp. (STEK), closed Tuesday's trading session at $0.145, off by 6.9917%, on 325,038 volume. The average volume for the last 3 months is 1.017M and the stock's 52-week low/high is $0.12/$11.50.

Bit Digital Inc. (BTBT)

QualityStocks, MarketClub Analysis, StocksEarning, Schaeffer's, TradersPro, StockEarnings, MarketBeat, InvestorPlace and Daily Trade Alert reported earlier on Bit Digital Inc. (BTBT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Bit Digital (NASDAQ: BTBT), a digital asset mining company headquartered in New York, has announced its unaudited bitcoin production and corporate updates for the month of November 2022. Among the highlights the company reportedly earned 144.1 bitcoins, a 5% decrease compared to the prior month. The decline is attributed to an increase in network difficulty. In addition, Bit Digital owned 38,593 bitcoin miners and 730 ethereum miners as of Nov. 30, 2022, with an estimated maximum total hash rate of 2.7 exahash (“EH/s”) and 0.3 terahash (“TH/s”), respectively. Of the company’s bitcoin mining fleet, 39% (14,978 bitcoin miners representing 1.40 EH/s) was actively hashing in North America as of Nov. 30, 2022.

To view the full press release, visit https://ibn.fm/Es5U4

About Bit Digital Inc.

Bit Digital is a bitcoin mining company headquartered in New York City with operations located in North America. For additional information, please contact IR@bit-digital.com or visit the company’s website at www.Bit-Digital.com.

Bit Digital Inc. (BTBT), closed Tuesday's trading session at $0.7801, off by 10.0749%, on 1,017,327 volume. The average volume for the last 3 months is 203,528 and the stock's 52-week low/high is $0.7763/$8.66.

Compass Pathways PLC (CMPS)

QualityStocks, InvestorPlace, MarketBeat, Daily Trade Alert, StreetInsider, Schaeffer's, Trades Of The Day and The Street reported earlier on Compass Pathways PLC (CMPS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Ayahuasca is a psychedelic brew that is usually made from the Psychotria viridis and  Banisteriopsis caapi plants. The psychedelic has an incredibly long history in South America, with ancient Amazonian tribes using it for religious and spiritual purposes centuries ago. Even though ayahuasca is still used for religious and spiritual reasons by certain communities in Brazil and North America, recent research into psychedelics has also revealed that it has medical applications.

Studies have found that ayahuasca may be able to aid in the treatment of certain psychiatric disorders and addictions, but most researchers agree that more analysis is needed to increase knowledge of the psychedelic’s potential health benefits as well as its side effects.

With the world in the midst of a “psychedelic renaissance,” a period that has been characterized by significant investment in psychedelic research, more and more researchers are carrying out such studies.

A recent study on the psychoactive South American drink sought to determine if consuming the drink can result in any side effects, a facet of the psychedelic that has received relatively little attention. The study, whose findings were reported in the “PLOS Global Public Healthjournal, ran from 2017 to 2019 and involved more than 10,000 participants across some 50 countries.

A reported 47% of the respondents were Brazilian while Europe and North America accounted for 24% and 15% of the participant pool. Respondents filled out an online questionnaire and detailed the side effects they experienced after consuming ayahuasca.  Nausea and vomiting were by far the most common side effects at 62% followed by headaches at 17% and abdominal pain at 13%. At least 2% of the respondents had to receive medical attention due to these physical side effects.

On the mental side of things, 42% reported emotional-cognitive side effects such as disturbed thoughts and nightmares while 38% said that they experienced altered perception after their ayahuasca session.

Older people, individuals with more experience using the psychedelic brew, those with existing health conditions or a past alcohol-use disorder were more likely to report physical symptoms. Respondents who used ayahuasca unsupervised also reported experiencing physical side effects in higher numbers.

On the other hand, the mental or cognitive side effects were more likely to impact individuals with lower lifetime use of ayahuasca and those with previous anxiety issues. Traditionally, such side effects are seen as part of the psychedelic experience, with the cognitive effects being central to spiritual growth and physical symptoms such as vomiting seen as a form of purging.

However, many psychedelics startups such as Compass Pathways PLC (NASDAQ: CMPS) are looking to come up with psychedelics-based formulations that minimize the side effects of these drugs while maximizing the benefits.

Compass Pathways PLC (CMPS), closed Tuesday's trading session at $10.33, off by 4.2632%, on 203,528 volume. The average volume for the last 3 months is 6.019M and the stock's 52-week low/high is $6.54/$29.75.

Hecla Mining Company (HL)

MarketClub Analysis, SmarTrend Newsletters, Schaeffer's, InvestorPlace, Wyatt Investment Research, MarketBeat, Lebed.biz, StocksEarning, Top Pros' Top Picks, QualityStocks, TopStockAnalysts, StreetAuthority Daily, INO.com Market Report, The Street, Money Morning, Zacks, Marketbeat.com, Jason Bond, Kiplinger Today, Daily Trade Alert, StreetInsider, Today's Financial News, Wall Street Grand, Trades Of The Day, TheStockAdvisors, Streetwise Reports, StockOodles, The Wealth Report, TradersPro, Gryphon Digest, Penny Detectives, National Inflation Association, SureMoney, TradingAuthority Daily, Stockhouse, Darwin Investing Network, ChartAdvisor, PennyStockLive, Options Elite, INO Market Report, Wall Street Daily, Penny Sleuth, Profit Confidential, ProfitableTrading, TraderPower, The Growth Stock Wire, Daily Markets, Greenbackers, Forbes, DrStockPick, Wealth Insider Alert, TradingMarkets, WealthMakers, Investopedia, CustomerService, CRWEWallStreet, CRWEPicks, CRWEFinance, Weiss Research, BestOtc, Barchart, Daily Wealth, MarketArmor.com, AllPennyStocks, PennyToBuck, MonsterStocksPicks, Residual Income Report, Money and Markets, Rockwell Trading, Investing Futures, Stock Stars, Traders For Cash Flow, StockHotTips, Trade of the Week, InvestorGuide, Investor Update, Investor Guide, Investing Lab, PennyOmega and SmallCapVoice reported earlier on Hecla Mining Company (HL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

As beneficial as mining has been to the development of human civilization, the impact it has had on the environment is devastating. Mineral extraction over the centuries has at times contributed to the contamination of local streams and wetlands, deforestation, soil erosion, contamination and alteration. The global mining industry is estimated to produce roughly 4% to 7% of the worldwide greenhouse gas emissions.

With the environmental impacts of industries such as mining becoming clearer by the day, there has been increased interest in mining processes that consume less energy and have a smaller environmental impact. Researchers from the Guangzhou Institute of Biochemistry in China have come up with one such method, devising a technique called electrokinetic mining (EKM) that allows miners to extract rare earth metals from weathering crusts in a significantly greener and more efficient manner.

The novel technique involves exerting a voltage on both the bottom and top of the ion-adsorption rare earth deposits (IADs), generating an electric field that accelerates water and REE migration toward the cathode.

Heavy rare earth metals (HREE) such as yttrium, terbium, holmium, erbium and lutetium are extremely rare but play a significant role in critical technologies, including clean energy. The ion-adsorption deposits that occur within weathering crusts provide more than 95% of the world’s total HREE demand.

These metals are most commonly mined using ammonium-salt-based leaching techniques that have low recovery efficiency and cause significant damage to the environment. As such, miners are generally barred from adopting these techniques, which increases the metals’ scarcity and threatens to cause disruptions to the already strained supply chain.

Electrokinetic mining would decrease the use of leaching agents by more than 80%, reduce metallic impurities in obtained rare earth metals (REE) by more than 70% and increase efficiency by more than 90%. If this technique is deployed in mass, it could significantly reduce the environmental impact of HREE metal mining and make the process much more efficient than it currently is.

Results from bench-scale experiments carried out by the researchers show that the EKM technique achieved an REE recovery efficiency rate that was 2.6 times higher than the rate achieved in ammonium leaching techniques. Overall, the scientists’ experiments revealed that the EKM technique needed less treatment time and had a higher recovery efficiency compared to the ammonium-salt-based leaching techniques that are used to mine HREEs.

When the scientists applied the novel electrokinetic mining technique to an actual IAD, they found that it increased REE recovery efficiency by more than 90% in 264 hours.

It would be interesting to learn what extraction companies such as Hecla Mining Company (NYSE: HL) think about the economies of deploying this electrokinetic approach to mining at scale.

Hecla Mining Company (HL), closed Tuesday's trading session at $5.33, off by 0.559702%, on 6,066,030 volume. The average volume for the last 3 months is 61.922M and the stock's 52-week low/high is $3.41/$7.66.

NIO Inc. (NIO)

Green Car Stocks, InvestorPlace, Schaeffer's, The Street, MarketClub Analysis, MarketBeat, Daily Trade Alert, Trades Of The Day, StocksEarning, Kiplinger Today, The Online Investor, StreetInsider, QualityStocks, Zacks, StockMarketWatch, INO Market Report, BUYINS.NET, Cabot Wealth, Early Bird, Wealth Insider Alert, The Wealth Report, CNBC Breaking News, InvestorsUnderground, Investopedia, Daily Wealth, TradersPro, wyatt research newsletter, Energy and Capital, Investors Alley, CRWEWallStreet, FreeRealTime, Jim Cramer, Wealth Daily, InvestorsObserver Team, AllPennyStocks, MarketClub, TopPennyStockMovers, Top Pros' Top Picks, Stock Market Watch and InvestorIntel reported earlier on NIO Inc. (NIO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Since the introduction of electric vehicles, more people are showing increasing interest in buying them to the extent of ditching their favorite gas-powered brand for electric vehicles. As a result, Toyota and Honda, which have been slow in transitioning, are losing their devoted customers to companies that are already fully electrifying.

Ford and General Motors, along with Hyundai, are replacing Toyota and Honda’s gas-powered vehicles with new electric vehicles, as Tesla maintains its position as a leading car manufacturer.

Tesla once had nearly complete control of the market for electric vehicles in the United States, but it eventually lost some of that control when rival companies entered the market and began competing for the attention of the many drivers considering the transition to EVs. According to the most recent statistics, Tesla continued to hold at least 65% of the U.S. market during the first, second and third quarters of 2022, as Tesla models accounted for three-quarters of the 525,000 newly registered electric vehicles.

The U.S. market for electric vehicles has passed the 6% mark, an increase from the 2.2% witnessed last year, thanks in large part to Tesla’s expansion as growing numbers of people prefer electric cars over gas-powered ones. Currently, Tesla is putting its focus on the U.S. EV market.

Customers who previously drove gas-powered vehicles are now switching to electric vehicles. The S&P Global Mobility data reveals an obvious shift in customer preferences in favor of electric vehicles. While Toyota and Honda companies are suffering from some of their most well-liked models being traded in for electric vehicles, it is indeed a happy opportunity for manufacturers who did embrace EV technology quickly. The data shows the EVs that consumers are buying in exchange for their gas cars.

According to the data, EVs are indeed displacing gasoline-powered vehicles. The pattern suggests that Tesla, along with Ford, General Motors and Hyundai, have significantly contributed to full electrification.

Ford revealed in an announcement that it has produced 150,000 Mustang Mach-Es so far. This is an attempt to hit a production target rate of 2 million units as we approach the year 2026. Car manufacturers from other companies are also reaching comparable achievements as they attempt to fill the void Tesla left. We can see that the goal of the EV automakers, persuading consumers to choose emission-free vehicles, is being accomplished.

A point worth noting is that Toyota and Honda, which have gone slowly in transitioning to electric options, are likely to lose more of their devoted customers as drivers continue to adopt fully electric vehicles from different manufacturers such as NIO Inc. (NYSE: NIO).

NIO Inc. (NIO), closed Tuesday's trading session at $13.24, up 3.4375%, on 62,747,576 volume. The average volume for the last 3 months is 254,534 and the stock's 52-week low/high is $8.375/$35.55.

The QualityStocks Company Corner

Flora Growth Corp. (NASDAQ: FLGC)

The QualityStocks Daily Newsletter would like to spotlight Flora Growth Corp. (NASDAQ: FLGC).

As the Cannabis Control Board of Nevada had earlier announced,regulators held two lotteries on last week to pick the first set oflicensees that will be allowed to open marijuana consumptionlounges in the state. A total of 40 licenses were awarded during the lotteries.

 

Half of the licenses went to existing marijuana businesses thatwished to add consumption lounges to their facilities while theother half went to companies that wished to open standalonecannabis consumption lounges. Of this number, 10 went tosocial-equity applicants while the remaining 10 went to otherapplicants that didn’t fall in the category of social-equityapplicants.

During the lottery, regulators had a livestream of all theparticipating application numbers entered into the draw. All thenumbers that were randomly selected were published, and the agencyalso later published online the names of the companies that hadbeen selected to receive licenses.

That aside, the new licensees are expected to start serving thepublic in the first part of 2023. This step marks yet anotherforward step for the legal cannabis industry around the country,including for players such as Flora Growth Corp. (NASDAQ: FLGC) in jurisdictions elsewhere.

Flora Growth Corp. (NASDAQ: FLGC) is an internationally focused cannabis brand builder that leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions, including cosmetics, hemp textiles, and food and beverage. Flora Growth operates one of the largest outdoor cultivation facilities in the world with an aim of marketing a higher-quality premium product at below-market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, the company creates premium products that help consumers restore and thrive.

Flora Growth completed the first traditional cannabis IPO on Nasdaq in May 2021. Although currently headquartered in Toronto, Ontario, with plans to relocate its head office to Miami, Florida, the company’s base of operations is in Colombia, where it has built an extensive distribution network that includes Colombia’s largest distributors.

Currently, Flora Growth is organically growing market share for its existing brand portfolio (pharmaceuticals, textiles, cosmetics, and food & beverage) while seeking revenue-generating acquisitions that offer an accretive distribution network to amplify revenue growth.

Existing Brand & Product Portfolio

Flora Growth’s portfolio spans a number of verticals – each with a thoughtful brand designed to resonate with its intended end consumer. In line with the company’s mission, each brand prioritizes natural ingredients and value-chain sustainability.

Flora Lab S.A.S

Flora Lab is the company’s GMP certified manufacturing and R&D center focused on producing pharmaceuticals, cosmetics, and nutraceuticals for domestic and international markets. Its offerings include product lines that are private label, white-label, and custom formulas.

Through Flora Lab, Flora Growth has relationships with 1,500+ distribution channels, manufactures 63+ OTC products registered with INVIMA (Colombia National Food and Drug Surveillance Institute), and holds multiple GMP certifications enabling international export in an effort to leverage Flora Lab’s capacity to produce a wide range of CBD-infused products.

Flora Beauty

Flora Beauty is the company’s CBD beauty and cosmetics division founded by fashion and beauty industry icon Paulina Vega. Its current offerings include two CBD skincare brands targeting the U.S. and Latin American markets – MIND NATURALS and AWE. These lines exemplify Flora Growth’s socially conscious approach to business.

Currently, Flora Beauty products are offered globally through e-commerce, as well as through Falabella’s 111 retail locations across Latin America. The company is in negotiations with major department stores to launch the line in the U.S. and is also exploring opportunities in the U.K. and other European markets.

KASA Wholefoods

KASA Wholefoods is a Colombian manufacturer of food and beverages leveraging responsibly sourced exotic fruits from the Amazon. KASA has a $10 million+ distribution agreement with Tropi, Colombia’s largest food distributor, which has 130,000+ distribution points across the country.

Mambe, KASA’s leading brand, is already offered through over 980 distribution points across Colombia. Flora Growth expects this network to grow to over 1,200 distribution points in 2021, including one of Colombia’s largest coffee chains, Tostao Café & Pan.

Hemp Textiles & Co.

Through its Hemp Textiles division, Flora Growth intends to utilize its large land package and cultivation infrastructure to capture market share in the rapidly growing hemp industrials segment.

The company’s first brand through this division, Stardog Loungewear, offers a line of comfortable loungewear made from natural, organic materials. Stardog has been distributing globally through e-commerce and brick and mortar channels in Bogota since fall 2020, and the company intends to open U.S. brick and mortar locations in 2021.

Accretive M&A

Flora Growth is targeting transactions to complete the supply chain via key infrastructure to enhance its global distribution with the aim to compete on low-cost, high-quality inputs paired with premium brands that create business lines with robust margins.

To date, Flora has announced two major transactions.

Koch & Gsell (Acquisition)

  • Amplify CPG portfolio’s revenue growth through leading brand, Heimat, currently with TTM revenues of $7.6 million.
  • Leverage Koch &Gsell’s distribution network of 2,500+ stores to introduce Flora to the Swiss, European and Asian markets.
  • Bring patented hemp cigarette manufacturing technology into new markets utilizing Flora’s high-quality cannabis.

Hoshi International (Investment)

  • Equity Investment of €2 million into Hoshi to establish Flora as a preferred supplier to two EU processing facilities.
  • Opens gateway for Flora Growth’s cannabis through international distribution agreements in the EU and U.K.
  • Hoshi’s experienced team and increased access to the EU cannabis market to serve as a catalyst for revenue growth.

Cultivation

Key to Flora Growth’s expansion efforts is its cultivation strategy. The company’s Cosechemos farm, located in Bucaramanga, Colombia, is currently licensed to cultivate 247 acres of cannabis. Through three successful pilot crop plantings, the location has demonstrated a production cost of just $0.06/gram. For comparison, the average cost of North American cannabis (based on 2019 figures from Aphria, Tilray, Sundial, and Aurora) equates to roughly $1.89/gram.
Flora Growth is uniquely positioned to capitalize on Colombia’s favorable growing conditions, low-cost infrastructure, and affordable local workforce as it looks to ramp up its cultivation efforts moving forward.

Leadership Team

Bernard Wilson is the Chairman of Flora Growth. A senior financial professional, Dr. Wilson is the former Vice-Chairman of PricewaterhouseCoopers LLP and is the Chairman of the Founders Board of the Institute of Corporate Directors. He has also served as Chairman of the Canadian Chamber of Commerce; Chairman of the International Chamber of Commerce – Canada; and Member of the Canada/U.S. Trade Committee. Dr. Wilson draws on this experience to ensure Flora Growth adheres to effective corporate governance practices.

Luis Merchan is the company’s President and CEO. He is a proven executive with over a decade of experience in enterprise sales management, corporate strategy, merchandising and expense management, and customer experience. Mr. Merchan previously served as Macy’s Inc.’s Vice President of Workforce Strategy and Operations, where he managed the enterprise’s multi-billion-dollar P&L expense line for the entire 540 store portfolio. Throughout his tenure at Macy’s, he led various sales and marketing initiatives, including the B2B corporate sales team that was responsible for $160 million in annual revenue. Mr. Merchan obtained his Bachelor of Industrial Engineering from Pontifical Xaverian University in Bogota, Colombia, and his MBA from McNeese State University. He also holds a Graduate Certificate in Marketing Management from Harvard.

Juan Manuel Galan is a Strategic Advisor to the Flora Growth management team. Mr. Galan currently serves as a senior consultant to The World Bank. He is a politician and former senator of Colombia, serving three terms from 2006 to 2018 as a member of the Colombian Liberal Party. He is also a former professor at the University of Rosario and holds more than 20 years of journalistic, academic, governmental and parliamentary experience. During his time as a senator, Mr. Galan was a key leader, with 29 bills and 27 debates on political control, and 17 laws to his name. The most relevant of those laws was authoring the medical cannabis law that resulted in the legalization of medical cannabis in Colombia.

Stan Bharti is a Director of Flora Growth. Mr. Bharti currently serves as Executive Chairman of Forbes & Manhattan. He has more than 30 years of professional experience in business, finance, markets, operations and more, with a focus on the resource and technology sectors. To date, Mr. Bharti has amassed over $3 billion worth of investment capital for the companies with which he has worked and their shareholders. He is a Professional Mining Engineer and holds a master’s degree in engineering from Moscow, Russia, and University of London, England.

Javier Franco is the company’s VP of Agriculture. Mr. Franco is a master horticulturist with more than 25 years of experience in the design, implementation, and management of cultivation and propagation facilities of more than 30 species of cut flowers in Latin America. He completed his agricultural studies at Zamorano University in Honduras and later at an International Exchange Program at Ohio State University. Mr. Franco has directed technical, commercial, and research groups in the cut flower, fruit and vegetable markets in Latin America and has participated in the commercial development of new technologies applied in agribusiness. He has also led the agri-management of organic crops and certifications of Good Agricultural Practices.

Flora Growth Corp. (FLGC), closed Tuesday's trading session at $0.4778, up 2.3784%, on 255,777 volume. The average volume for the last 3 months is 43,002 and the stock's 52-week low/high is $0.3668/$2.38.

Recent News

SideChannel Inc. (OTCQB: SDCH)

The QualityStocks Daily Newsletter would like to spotlight SideChannel Inc. (OTCQB: SDCH).

FinCEN reported 1,489 incidents of ransomware totaling close to$1.2 billion in 2021, a value that has doubled from 2020

Key industries experiencing a high need for cybersecurity solutionsinclude fintech, biotech, healthcare, manufacturing, legal defense,and technology services

The global healthcare cybersecurity market is expected to reach$57.25 billion by 2030, growing at a CAGR of 16.3% from 2021 to2030

SMBs have experienced an increase in cybersecurity threats due toremote-based work and in-office workers depending on cloud-basedsolutions, mobile devices, software applications, and third-partysuppliers to conduct business

SideChannel’s goal is to make cybersecurity simple and accessible,offering a wide range of solutions to identify, evaluate, andtackle risks

In the United States, financial institutions are required to filesuspicious activity reports to help the government detect moneylaundering or other criminal activities – including securitybreaches. The Financial Crimes Enforcement Network's (FinCEN)analysis indicates that ransomware continues to pose a significantthreat to the United States critical infrastructure sectors,businesses, and the public. In 2021, financial institutions filed1,489 incidents related to ransomware – nearly $1.2 billion inlikely ransomware-related payments, more than double the amountfrom 2020. According to FinCEN, the amounts within its analysisinclude extortion amounts, attempted transactions, and paymentsthat were not made (https://ibn.fm/Jz58w).SideChannel (OTCQB: SDCH) simplifies cybersecurity for mid-market companies. The company’smission is to make cybersecurity simple and accessible, based on abelief that small and mid-sized organizations (“SMBs”) deserve theexpertise of an experienced Chief Information Security Officer(“CISO”) just as much as larger enterprises, but at a reasonablecost.

SideChannel Inc. (OTCQB: SDCH) simplifies cybersecurity for mid-market companies by matching them with highly experienced information security officers at a cost lower than building an in-house information security team or hiring a full-time CISO.

SideChannel’s team of virtual Chief Information Security Officers (vCISOs) possesses a combined 400-plus years of experience in cybersecurity. They’ve honed their skills and abilities in places like Anthem, Dick’s Sporting Goods, Best Buy, TD Bank and the Pentagon. SideChannel lends this talent to clients, creating value in the form of a bespoke cybersecurity program perfectly sized for the growing enterprise.

SideChannel is committed to creating top-tier cybersecurity programs for SMBs to help them protect their data and assets. To date, SideChannel has created more than 50 multi-layered cybersecurity programs for its clients.

 

Reports show that cyberattacks on SMBs have increased in recent years, as organizations’ network attack surfaces have grown exponentially with remote and in-office workers increasingly relying on cloud environments, mobile devices, software applications and third-party suppliers to conduct business.

SideChannel continues expanding its service offerings, workforce and customer base, attracting over 20 virtual CISOs to serve across industries including fintech, biotech, healthcare, manufacturing, legal, defense and technology services. The company is based in Worcester, Massachusetts.

Market Opportunity

An analysis from ReportLinker states that the global cybersecurity market is expected to grow from an estimated value of $173.5 billion in 2022 to $266.2 billion by 2027, recording a CAGR of 8.9% for the period.

The increased number of data breaches worldwide, the ability of malicious actors to operate from anywhere in the world, the links between cyberspace and physical systems, and the difficulty of reducing vulnerabilities and consequences in complex cyber networks are some factors driving cyber security market growth, according to the report.

A lack of cybersecurity professionals and the budget constraints among SMBs and start-ups in developing economies are expected to hinder market growth. Cybercriminals are using automated techniques to attack SMBs’ networks to take advantage of their weak security infrastructures. To save money, time and resources, SMBs are seeking cybersecurity solutions.

Enclave

Enclave expands upon SideChannel’s cybersecurity service offerings by solving a pervasive network security problem with a simple tool.

A comprehensive cloud and network security solution, Enclave enables IT teams to contain breaches faster, reduce network outages, minimize latency and strengthen overall security defense.

Enclave creates the foundation for a Zero Trust network security model IT can build upon.

With Enclave, IT can easily segment their company’s network, organize personnel and computing devices at the employee workload level, and implement security controls across all network segments.

Enclave was designed and purpose built to serve the growing security needs of SMBs, a traditionally underserved market that is more prone to cyberattacks but has limited protection due to smaller budgets, inadequate IT security staffing and a lack of cybersecurity awareness among top executives.

Enclave is an affordable and effective network security solution that shrinks the attack surface area exposed to a cyber intruder and significantly reduces the amount of effort required to operate securely.

Management Team

Brian Haugli is CEO of SideChannel. He has led programs for the U.S. Department of Defense, the Pentagon, and Fortune 500 companies. He is an expert on National Institute of Standards and Technology guidance, threat intelligence implementations and strategic organizational initiatives. He is a professor at Boston College, Woods College of Advancing Studies Master’s Program in Cybersecurity. He is also a contributing author for the Wiley book ‘Cybersecurity Risk Management’.

Ryan Polk is CFO at SideChannel. He has been the principal of Perissos Partners, an executive consulting firm, since June 2017. He also served in executive roles in the portfolio companies owned by Lacy Diversified, with combined revenue approaching $2 billion. He served as the Vice President for Corporate Financial Planning and Analysis for Brightpoint, a publicly traded, Fortune 500 mobile device logistics company. He earned a bachelor’s degree in accounting and industrial management from Purdue University.

Nicholas Hnatiw is Chief Technology Officer at SideChannel. Prior to joining the company, he served as the technical director for network operations supporting U.S. Cyber Command, U.S. Intelligence Agencies and other Department of Defense research organizations. He was also the CEO of Loki Labs, a cyber security firm. He earned a bachelor’s degree in computer engineering and computer science at the University of Massachusetts, Amherst.

Bill Roberts is SideChannel’s CISO. He most recently served as the vice president, IS & CISO for Hologic Inc., a global medical device company, where he established cyber security and IT compliance programs. Prior to Hologic, he was vice president of information security for Cytyc Corporation, which was acquired by Hologic in 2007. At Cytyc, he managed global IT as the company grew from 140 employees to 1,500 and from $40 million in revenue to over $750 million.

SideChannel Inc. (OTCQB: SDCH), closed Tuesday's trading session at $0.1097, up 5.4808%, on 43,002 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $2.38/$.

Recent News

Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F)

The QualityStocks Daily Newsletter would like to spotlight Hillcrest Energy Technologies Ltd. (OTCQB: HLRTF).

Hillcrest (CSE: HEAT) (OTCQB: HLRTF), a clean tech company developing transformative power conversiontechnologies and control system solutions for next-generationelectrical systems, today announced the completion of its 800-volt,250-kilowatt Zero Voltage Switching (“ZVS”) traction invertercommercial prototype. “We’ve validated our core technology and willcontinue working with Hercules Electric Mobility and a tier 1automotive supplier, our previously announced co-developmentpartners, on integrating our ZVS traction inverter into theirspecific powertrain applications,” said Hillcrest CTO Ari Berger.“Implementing our technology in these systems, expected to occur byQ2 2023, will mark another important milestone by transitioning thetechnology out of our lab and into real-world demonstrations of theHillcrest ZVS inverter in commercial applications.”

To view the full press release, visit https://ibn.fm/VXcMQ

Hillcrest Energy Technologies Ltd. (CSE: HEAT) (OTCQB: HLRTF) (FRA: 7HIA.F) is a clean technology company based in Vancouver, British Columbia, engaged in developing high-value, high-performance power conversion technologies and digital control systems for next-generation powertrains and grid-connected renewable energy systems.

From concept to commercialization, Hillcrest invests in the development of energy solutions that power a more sustainable and electrified future. Hillcrest power inverter technology helps produce efficiencies in electrification and maximize the performance of electric systems, including electric vehicles (EV), motors and generators.

The company offers a flexible, single-inverter architecture that can be applied at nearly every stage of the electrification ecosystem, from renewable energy generation through the charging and operation of an EV, to provide full-cycle efficiency and performance improvements.

As momentum to electrify and decarbonize energy systems accelerates, Hillcrest believes the power inverter is increasingly emerging as a key component. While system cohorts such as battery packs, PV panels and electric motors are often in the spotlight, the inverter holds the key to unlocking efficiency and performance improvements.

Hillcrest power inverter technology is:

  • REVOLUTIONARY: high-efficiency inverter technology has the potential to revolutionize how motors respond and how efficiency is gained.
  • AGILE: able to deliver and deploy high-efficiency inverter solutions purpose-designed to meet specific customer needs.
  • INNOVATIVE: technology-forward, clean-energy experts who are focused on advancing and optimizing efficient alternative energy use across all electric vehicle and charging platforms.
  • A MARKET LEADER: a next-generation technology provider to the automotive industry’s top suppliers and manufacturers.

Technology & Applications

Hillcrest’s first application for its inverter technology – a 250 kW|800V Hillcrest SiC high efficiency traction inverter – is focused on the growing EV market. Hillcrest technology eliminates traditional design trade-offs faced across the power industry – deploying higher switching frequencies has historically meant a greater increase in losses, lower system efficiency and higher heat. Through a combination of hardware and software expertise, Hillcrest enables power applications to leverage higher switching frequencies AND

  • Realize improved power system performance and reliability
  • Operate at higher power levels without compromising efficiency

The expected benefits of Hillcrest’s traction inverter have been confirmed via testing and shared in a technical white paper, published in April 2022, that confirmed the following results:

  • Significant efficiency gains – 99%-plus inverter efficiency
  • Increased power density targeting 50kW/L+
  • Significantly increased motor efficiency
  • Lower stress on mechanical and electrical parts, enhancing reliability
  • Improved thermal management

Hillcrest has also filed a patent for an enhanced powertrain solution that offers the potential to simplify EV charging and redefine how the industry envisions charging infrastructure. The company believes the most exciting benefit of the enhanced powertrain solution is the ability to eliminate the onboard charger and booster from an EV, as well as faster, anywhere charging including direct DC, wireless, and bidirectional charging across current and future power levels. Hillcrest sees this as a true EV charging game changer.

The company’s technology applies to nearly every clean energy industry segment:

  • Wind power – an inverter is deployed at a wind turbine generator to convert the AC output, with at least one additional inverter used to deliver the power to the grid/battery.
  • Solar power – an inverter is used to convert the DC output from the photovoltaic panels into the AC power that flows to the grid/battery/home.
  • Energy storage – an inverter is deployed to convert the DC output from the storage system or batteries to the AC power that flows to the grid/home/EV.
  • EV fast chargers – an inverter converts the AC input from the grid/storage system to the DC output needed to charge an EV’s battery.

Market Outlook

According to an April 2022 market analysis by Vantage Market Research (VMR), the global power inverter market is expected to reach a value of $95 billion by 2028, driven by increasing demand for EVs, energy generating wind turbines and solar-powered photovoltaic systems. That jump is forecast from an estimated $70.5 billion market value in 2021 and represents a compound annual growth rate of more than 5%.

According to the VMR report, many governments in countries around the world are supporting alternative options for efficient and nonpolluting energy generation. This has boosted demand for wind energy and solar energy systems. Hillcrest is aiming to capture a share of this future market growth across nearly every segment of the clean energy industry.

Management Team

Don Currie is the founding CEO of Hillcrest Energy Technologies. He has led the company’s successful transition from fossil fuels into clean energy technologies. Earlier in his career, he held various senior level positions, including director, officer and vice president of corporate communications with Enhanced Oil Resources Inc., an oil and gas exploration and production company based in Houston. Prior to that, he worked in other private and public ventures spanning the mining, gaming and technology sectors.

Jamie L. Hogue is the COO of Hillcrest. She brings more than two decades of progressive policy leadership, economic analysis and organizational development experience to Hillcrest. She builds collaborative processes and solutions that drive growing organizations toward a more resilient future. She previously served as the director of operations for Arizona State University’s Ten Across initiative – a compelling observatory positioned on the front lines of economic, social and climate change. She earned a master’s degree in public administration and a bachelor’s degree in economics from Arizona State University.

Ari Berger is Chief Technology Officer at Hillcrest. He brings over a decade of commercial experience with a track record of deploying new electrification technologies and go-to-market strategies. In 2015, he founded NIG Systems Ltd. in Israel, which specializes in custom high performance control systems design. Prior to this, he previously worked for Bental Industries, a leading motor manufacturer. He holds a master’s degree in system control engineering from the Technion – Israel Institute of Technology.

Raj Clair is CFO at Hillcrest. She is a CPA who began her career at Deloitte and has served in advanced finance positions in the energy and resources sector. She has been responsible for reporting, audits and internal controls, as well as working on budgeting and forecasting. She has worked with various publicly listed companies, including SEC registrants, and has both Canadian and U.S. experience. She holds a bachelor’s degree in accounting from Simon Fraser University.

Hillcrest Energy Technologies Ltd. (NASDAQ: HLRTF), closed Tuesday's trading session at $0.0751, up 3.5862%, on 66,943 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.072/$0.1724.

Recent News

Coyuchi Inc.

The QualityStocks Daily Newsletter would like to spotlight Coyuchi Inc.

  • SEC Regulation A+ is an exemption from registration for publicoffering, which allows investors to invest in non-listedcompanies
  • Millennials are favoring ethical consumption over price whenpurchasing goods and services; Coyuchi is leveraging thismarket with its sustainable and environmentally friendly luxuryhome goods
  • Coyuchi has spent three decades exploring organic farming andsustainability in textiles, achieving high-qualitycertifications, including The Global Organic Textile Standard(“GOTS”), Fair Trade Certified, and MADE SAFE(R)
  • The company is targeting four core markets – bedding, bath,apparel, and lifestyle – covering markets that ethicallyconscious millennials are penetrating
  • The global organic bedding market was valued at $836.4 millionin 2020 and is expected to reach $1.1 billion by 2025, growingat a CAGR of 5.1%

Coyuchi, the gold standard in sustainable luxury home goods, uses only100% organic cotton materials to manufacture textiles, includingluxury organic bedding, sheets, towels, apparel, and other productsfor the environmentally conscious homeowner. The company iscurrently accepting investment as part of a Regulation A+ (Reg A+)offering. Coyuchi’s profile can be found on Manhattan StreetCapital’s site (https://ibn.fm/lEYSo) or through the updated offering circular (https://ibn.fm/w861s).

Coyuchi is the gold standard in sustainable luxury home goods. The company offers sustainably produced luxury organic bedding, sheets, towels, apparel, and other home goods for the environmentally conscious home. With a timeless, coastal-inspired aesthetic, Coyuchi uses only 100% organic cotton materials to manufacture all of its textiles.

The Company was built upon four foundational pillars: protect the planet, innovate circular design, live sustainably, and enrich the community. These guiding principles have proven an effective market strategy. In 2021, Coyuchi earned $33.3 million in net sales, amounting to 26% YoY growth (the industry average is only 5%). It also experienced 2x customer growth to 200,000 active customers, averaging a 35% customer repeat purchase rate.

With a seasoned leadership team, a robust e-commerce shopping experience, and a healthy customer base that drives the fast-growing organic luxury market, Coyuchi is prepared to propel a new phase of growth as the rest of the world finally awakens to sustainability at scale.

A Lucrative Market Ripe for the Taking

The global market for organic bedding, which was estimated at $814.3 million in 2020, is projected to reach $1.1 billion by 2027, growing at a CAGR of 4.9% over that period, according to Research and Markets. More specifically, the domestic organic bedding market is estimated at $240.1 million in 2020, according to Statista. Overall, the U.S. market for home textiles is currently valued at $25 billion annually, and, with a forecast annual growth rate of 5%, it is expected to reach $30 billion by the end of 2025.

Grand View Research reported in 2020 that shifting consumer preference toward high-end lifestyle products is a key factor driving the growth of the organic bedding market. Seventy-four percent of consumers are willing to pay more for sustainable products – a consumer preference that has steadily increased over the last few decades. Millennials especially favor ethical consumption over price when purchasing goods and services, with 83% of millennials reporting that they want the brands they purchase from to align with their beliefs and values (https://ibn.fm/PANNV). With a majority millennial customer base, Coyuchi is poised to capitalize on this trend.

Industry Defining Sustainability Practices

For 30 years, Coyuchi has explored organic farming and sustainable textiles and guarantees the highest environmental and ethical standards through a number of certifications such as The Global Organic Textile Standard (GOTS), Fair Trade Certified, and MADE SAFE®.

Coyuchi continues to push the organic textile market forward through its circularity initiatives and by supporting cross-industry sustainability advocates. Coyuchi’s mission to bring beauty and comfort to every home without sacrificing the health of our planet has resulted in a number of important sustainability checks and balances.

  • A Circular Business Model: Coyuchi has cultivated a holistic 360-degree approach that contributes to the fight against climate change with its take back and recycling program, 2nd Home™. In 2017, it became the first luxury home brand to implement such an initiative, and, since then, the company has eliminated 68,758 lbs. of toxic chemicals from homes and renewed 6,000 lbs. of textiles.
  • The Coyuchi Climate Council: In early 2022, Coyuchi introduced a cross-disciplinary council with a goal of Net Zero Emissions by 2025 and Net Positive Emissions by 2030. The Coyuchi Climate Council brings together influential minds across fashion, regenerative farming, and sustainability who have the knowledge and experience necessary to achieve climate change.
  • C4: The California Cotton & Climate Coalition: Most recently, Coyuchi announced it is a founding member of C4, which includes innovative, sustainable fashion, apparel, and personal care brands like MATE the Label, Outerknown, Reformation, and Trace. Working together pre-competitively, C4 creates a structure for investing in regionally grown, Climate Beneficial™ cotton and directly supports the livelihoods of the farmers that grew it. Coyuchi is the only home industry brand currently involved in the project.

Omnichannel Business Model

Coyuchi differentiates itself through an omnichannel and circular business model, both of which have proven a clear draw for customers. It was an early adopter of an e-commerce sales and marketing approach (over 80% of its sales are directly through coyuchi.com), creating a distinct advantage over incumbents and start-up newcomers in the luxury space. This has resulted in a high lifetime value customer, luxury retail partners such as Nordstrom, and a flagship store in Marin County.

Coyuchi’s Organic Textile Products

Coyuchi’s product assortment consists of consciously designed bedding, bath, apparel, and lifestyle products spread across about 1,400 SKUs. The company believes that its product assortment, produced from 100% organic cotton with Global Organic Textile Standard (GOTS) certification, provides it with a significant competitive advantage. GOTS is the world’s leading textile processing standard for organic fibers, ensuring the organic status of textiles after harvesting raw materials through environmentally and socially responsible manufacturing all the way to labeling, a major environmental and social benefit over conventional cotton product production.

Coyuchi’s focused product assortment consists of four core categories:

  • Bedding – A full suite of sustainable, organic, and high-quality sheets, duvet covers, blankets, and throws.
  • Bath – A luxurious line of towels, bath rugs, and mats.
  • Apparel – Premium apparel for men and women, including robes, sweaters, pants, and pajamas.
  • Lifestyle – The lifestyle category offers 135 SKUs, from organic napkins to crossbody totes.

Management Team

Eileen Mockus is President and CEO at Coyuchi. She has more than 25 years of experience in retail, having held positions in textile development at Patagonia, Pottery Barn Teen, and The North Face. She earned a bachelor’s degree in textiles and clothing from UC Davis and an MSBA from San Francisco State University.
Sejal Solanki is Chief Marketing Officer at Coyuchi. She previously served as the company’s Vice President of E-Commerce. Before joining Coyuchi, she worked at teen clothing giant Charlotte Russe. She oversees the company’s digital marketing, site experience, brand marketing, and e-commerce strategy.

Marcus Chung is Coyuchi’s COO, overseeing supply chain, sourcing strategy, sustainability, and IT. He previously held positions at notable direct-to-consumer brands Third Love and Stitch Fix, as well as national retailer The Children’s Place. He holds a bachelor’s degree from Wesleyan University and an MBA from UC Berkeley’s Haas School of Business.

Margot Lyons is Director of Sustainability and Sourcing at Coyuchi, where she works with strategic partners to ensure all the company’s product sustainability standards are met. She received a master’s degree in textiles and clothing from UC Davis.

Use of Proceeds

This round of funding will be used to increase Coyuchi’s enterprise value through expanded marketing, product category expansion, continued physical presence, and B2B strategic partnerships with wholesalers, and online marketplaces.

Recent News

chart

Cub Crafters Inc.

The QualityStocks Daily Newsletter would like to spotlight Cub Crafters Inc.

CubCrafters, the leading designer and manufacturer of light-sport,experimental and Part 23 certified backcountry aircraft, hasannounced that its flagship certified CC19 XCub aircraft wasrecently selected by the United States Department of Agriculture(“USDA”) for a new government aircraft fleet modernizationcontract. Since 2003, CubCrafters has supplied the U.S. governmentwith aircraft that have been used by various agencies to completemissions in some of the most remote and extreme flyingenvironments. Manufactured under this most recent contract will bethe first certified XCub in fleet service with the U.S. governmentand will be primarily used for natural resources management.Delivery of the first two aircraft in the multiyear contract isscheduled for the late summer of 2023. “Our long relationship withthe U.S. government is a strong testament to our ability to designand manufacture exceptionally rugged utility aircraft forbackcountry missions,” said Patrick Horgan, CubCrafters’ presidentand CEO. “This contract is not only important for us as a supplierfor the U.S. government, but also for investors participating inour ongoing public offering. This sale demonstrates that our newestgeneration of fully certified modern utility aircraft can replacethe aging fleet of legacy aircraft now in service. It shows thatthere is a very bright future for our fleet sales program.”

To view the full press release, visit https://ibn.fm/xhvUK

Cub Crafters Inc. (typically styled CubCrafters) is an OEM aircraft manufacturer based at McAllister Field Airport in Yakima, Washington. The company was founded in 1980 to build parts and supplementary type certificate (STC) improvement modifications, which were used to establish it as the preeminent center for rebuilding the classic Piper PA-18 Super Cub light aircraft. CubCrafters went on to advance the market with its own, newly manufactured aircraft models and holds an approved Federal Aviation Administration (FAA) Production Certificate. Yakima-based operations include an engineering design-test-certification center, aircraft parts and assembly production facilities, and an MRO maintenance service and overhaul facility.

The first newly manufactured aircraft by the company, the CC18-180 Top Cub, was Federal Aviation Administration (FAA) type certified in December 2004. The Top Cub was also granted type certificates (TC) by Transport Canada in July 2008, followed by Australian certification in August of that same year. With the FAA’s release of the new Light Sport Aircraft (LSA) class, CubCrafters created a brand-new model in 2008, the CC11-100 Sport Cub, similarly based on the original Piper J-3 Cub’s appearance, which it validated to ASTM international standards as an LSA. This model advanced to become known as the Carbon Cub, the bestselling LSA of all time in the U.S.

CubCrafters focuses on four main product lines, including the Carbon Cub SS, Carbon Cub FX, XCub, and the Top Cub under license. Some models are built to be lightweight and powerful for quicker flights, while others are built for longer missions in unforgiving backcountry environments.

CubCrafters has a service and overhaul facility for PA-18 Super Cubs and other Cub derivative designs at its Yakima headquarters. The company sells aircraft kits as well as finished aircraft.

Aircraft

The Carbon Cub is available in three variants: Carbon Cub SS (production Light Sport Aircraft), Carbon Cub FX (an innovative Builder Assist E/A-B aircraft) and Carbon Cub EX (E/A-B aircraft kit). Carbon Cub has been designed for off-airport operation with a powerful engine, strong lightweight airframe and nimble low-speed manners. The Carbon Cub has taken the fundamentally superior design of the Piper Super Cub and reinvented it using 21st century materials and computer-aided design. Superior engineering results include the Carbon Cub having 50% fewer parts and weighing more than 300 pounds less than a similarly equipped Super Cub. Now in its third generation of innovation advancements, there are over 1,000 Carbon Cubs flying.

The CubCrafters CC19-180 XCub, FAA Certified and introduced in June 2016, is supplied complete and ready-to-fly. The XCub is a further scaled development of the CubCrafters Carbon Cub, which the company continues to supply, but with higher performance and incorporating more structural carbon fiber. The XCub was developed over a six-year period and not publicly announced until FAA TC had been completed and issued. The process was completed organically using company resources and did not involve any venture capital, loans nor any advanced customer deposits. XCub is built on a wholly original fuselage design. The CNC-milled 4130 chromoly steel frame meets the latest FAA Part 23 certification standards for 2,300-pound gross weight aircraft. XCub’s useful load is as high as 1,084 pounds. Current Part 23 certification requirements ensure this is the strongest Cub ever produced. It can fly farther, providing greater comfort. It is an airplane that has taken the best from the past and, using the very latest in design, material and manufacturing technology, has established a new standard.

The XCub was approved by the FAA for seaplane operations in December 2017. That same month, EASA approved the XCub design and issued a new type certificate. Four international type certificates have been gained: EASA Dec-2017, Canada Feb-2018, Japan April-2018, and Australia Aug-2018.

CubCrafters increased the horsepower of the XCub line in 2019, offering two new models: the CC19-215 FAA Certified version and the CCX-2300 Builder Assist, both powered by the new CC393i 215 HP engine built by Lycoming.

In December 2021, CubCrafters gained FAA Certification of a new nose wheel version of the XCub, branded the NXCub.

Market Overview

According to a 2022 analysis by research firm Expert Market Research (“EMR”), the global ultralight and light aircraft market was valued at $7.63 billion in 2021. The EMR report says the market is expected to grow at a CAGR of 4.5% in the forecast period of 2022-2027 to reach a value of $9.93 billion. Ultralight and light aircraft are small aircraft with on-board pilot (and perhaps passengers) designed for use in recreation, sports, pilot training, aerial surveys, mapping, research and agriculture, humanitarian backcountry access, and special military missions, as well as business and personal travel.

CubCrafters currently enjoys a dominant market share of the rugged adventure airplane market.

Management Team

Patrick Horgan is President and CEO at CubCrafters. Before he assumed that role, he was the company’s Vice President/Director of Engineering & Product Development for three years, when he led the FAA Part 23 type certificate approval and production certificate approval of CubCrafters’ newest flagship, the XCub. Mr. Horgan also directed the breakthrough certification that authorized the use of experimental avionics in FAA-certified production aircraft, a first in aviation history. He brings over 30 years’ aircraft development and manufacturing experience in general aviation, commercial, and military industries. Prior to service at the company, he was the General Manager at WACO Classic Aircraft Corporation in Battle Creek, Michigan, and was the commercial aircraft manager of the Boeing 777 wheel and brake program for Goodrich Aerospace in Troy, Ohio. He was also a designer on the F/A-18 Super Hornet at McDonnell Douglas (now Boeing) in St. Louis, Missouri. Mr. Horgan holds degrees in aeronautical and astronautical engineering from the University of Illinois, and a certificate in Disruptive Strategy from Harvard Business School. He serves as a member of the Board of Directors of the General Aviation Manufacturers Association and on ASTM aircraft standards committees.

Brad Damm is Vice President at CubCrafters. He has overseen CubCrafters’ sales, marketing, and brand management operations since 2018. Since first joining CubCrafters in 2013, Mr. Damm has served as Factory Direct Sales Manager, the Director of Sales Support, the Global Director of Sales, and the Vice President of Sales and Marketing. During his tenure, the company has seen new sales records year after year across all of CubCrafters new aircraft and kit product lines, and the CubCrafters brand has risen to new levels of awareness and respect with aviation consumers worldwide. Prior to joining the company, he served for over 10 years as the Business Development Manager for one of the largest commercial concrete contractors in the Pacific Northwest, driving the sales and revenue growth that allowed the company to expand from a few dozen to hundreds of employees.

Rick Johnson is the Director of Finance at CubCrafters and has been with the company since 2017. He has 27 years of previous experience as controller and CFO for fruit packing and timber operations in the Pacific Northwest. He holds a Bachelor of Science in Business Administration from Central Washington University.

Christopher Matus is Production Manager at CubCrafters and joined the company in 2011. Before taking that post, he held positions as Fabrication Plant Manager, Machine Shop Manager and CNC Machinist for the company. He has also served as a Combat Engineer in the Washington Army National Guard, deploying to Afghanistan and to natural disasters including the 2014 Oso Mudslide.

Justin Jansky is the Administrative Manager at CubCrafters. He joined the company in 2015 and has a demonstrated history of successful collaboration on major FAA type certification projects in the general aviation industry, specifically under 14 CFR Parts 21 and 23. He is responsible for process management, document control, facilitating FAA certification processes, coordination with FAA delegates and documenting compliance testing. He holds a bachelor’s degree in technology and applied design.


Recent News

chart

GeoSolar Technologies Inc.

The QualityStocks Daily Newsletter would like to spotlight GeoSolar Technologies Inc.

• Homes are responsible for 20% of carbon emissions in the U.S. and16% of carbon emissions in U.K.

• GeoSolar Technologies’ SmartGreen(TM) Home package can eliminate100% of a house’s carbon footprint and up to 60 trillion tons ofemissions when expanded to buildings and businesses

• With the addition of technologies, such as SmartGreen(TM) Homesystem, increases a home’s value by $15,000, according to the U.S.Department of Energy

When it comes to carbon emissions, factories and vehicles usuallyare the first to spring to mind for bellowing pollution. Whiletrue, U.S. homes are the sixth biggest carbon emitter in the world,creating 20 percent of the nation’s total carbon pollution. In theU.K., where homes responsible for 16 percent of the region’s carbonemissions, a new organization called Future Homes Hub is activelyspearheading a transition to sustainable homes, indicating theglobal nature of the push for net zero.

Future Homes Hub is chaired by David Thomas, CEO of U.K.residential property development juggernaut Barratt (LSE: BDEV),which has introduced a bevy of green technologies into its homes.“With the cost of living rising, energy efficiency has become a keydriver for our customers,” Thomas told Big Issue earlier this month.

In the U.S., companies like GeoSolar Technologies (“GST”) are specialized in green home packages that eliminatedependence upon the electricity grid while maximizing efficiencyand growing home value.

GeoSolar Technologies Inc. (“GST”) is a Colorado-based climate technology company and the creator of the Smart Green Home® system for newly built and existing residences and commercial buildings. The company is focused on revolutionizing the way we heat, cool and power homes with 100% natural energy sources. Its patent-pending integrated system harnesses energy from the earth and sun to power and purify homes and automobiles without the use of fossil fuels.

In a GST home, the sun’s energy is captured on the roof to generate all of the electricity required. Additionally, the consistent climate of the earth is used to keep the home at a perfect temperature year-round, and the company’s proprietary air purifying unit ensures that the air inside the home is safe and healthy.

GST’s home technology has been installed in multiple test homes in Colorado and achieved exceptional results, including some of the most impressive energy efficiency ratings (HERS) in the industry.

GeoSolar Technologies is currently accepting investment as part of a Regulation A+ offering. Everyone* can invest now for as little as $300. For more information, visit the company’s profile on Manhattan Street Capital and review its Offering Circular.

GeoSolar Technologies Inc. (“GST”) has been qualified by the U.S. Securities and Exchange Commission (SEC) to conduct a Regulation A+ capital raise. GST is already a publicly traded company who makes quarterly and annual filings with the SEC and is subject to quarterly PCAOB audits. This is the first time shares of GeoSolar Technologies are being made available for public purchase. Upon completion of this Regulation A+ offering, the company intends to seek a listing of its stock.

 

The Decarbonization Movement

Soaring and unstable energy/fuel costs continue to highlight the importance of rethinking the traditional approach to powering homes, from top to bottom. While most everyone is well aware of the remarkable, multi-trillion-dollar opportunity the electric vehicle transformation offers to investors (in addition to the benefits to the climate problem), few recognize that the all-electric home market is as large as electric vehicles and equally important to reducing carbon emissions.

U.S. energy expenditures clocked in at $3,891 per person in 2018, leading to estimated spending of $1.3 trillion on energy that year alone. Despite this, fewer than 3% of U.S. homes are currently powered by solar. This number is poised to increase exponentially as both new and existing residences transition to zero carbon models.

GST estimates that if all the homes in America were powered by its technology, carbon pollution could be reduced by an estimated 1.9 trillion pounds per year, greatly reducing the negative impacts on our climate.

GeoSolarPlus®

The GeoSolarPlus (“GSP”) system combines solar power, geothermal ground-sourced energy and other clean energy technologies into one fully integrated system.
Key benefits of the GSP system include:

  • Making a real planet-changing difference in reducing air pollution
  • Eliminating or significantly reducing homeowners’ future utility bills
  • Enjoying lifetime energy independence and protection from price escalation and energy shortages
  • Eliminating greenhouse gas emissions from operation of home and daily life
  • Increasing home value
  • An integrated design for seamless operation of renewable energy systems
  • Maintaining a significantly healthier living environment
  • Leveraging existing renewable energy tax credits and electrification incentives
  • Creating stable jobs capable of supporting families in the decarbonized future

Click here to learn more about how GeoSolarPlus works.

Management Team

The GST leadership and management team includes some of the world’s most experienced and respected leaders in the fields of decarbonization and sustainable homes.

Stone Douglass is the Chairman and CEO of GST. He is a seasoned, 30-year public company executive and former Chairman and CEO of the Piper Aircraft Company.

Brent Mosbarger is the company’s Co-Founder and leads its commercial operations. He is a highly respected solar engineer whose experience includes roles with Chevron Energy’s green operations and serving as project manager and executive for a $400 million solar/geothermal innovation project.

Peter Romenesko is a Senior Strategic Advisor with GST. He brings to the company considerable experience as an engineer and large-scale project manager for Johnson Controls and Siemens.

Dr. Norbert Klebl is the company’s Co-Founder and Development Director. Recognized as one of the world’s leading experts in the field of zero-carbon innovation, he is a former McKinsey partner of 16 years with an MBA from Columbia.

Dar-Lon Chang is GST’s Director of New Product Development. Prior to joining GST, he had a 16-year career with ExxonMobil Energy Research. He received his PhD in engineering from the University of Illinois.

* Must be over 18, certain states are not currently available and will be added soon.


Recent News

chart

MetAlert Inc. (OTC: MLRT)

The QualityStocks Daily Newsletter would like to spotlight MetAlert Inc. (OTC: MLRT).

MetAlert (OTC: MLRT), a pioneer in location-sensitive health monitoring devices andwearable technology products, today announced its selection of thecorporate communications expertise of IBN, a multifaceted financial news and publishing company for privateand public entities. With over 20 years of experience and anextensive portfolio of 30+ patents, MetAlert is a leading providerof innovative technology solutions to consumers/patients afflictedwith Alzheimer’s, dementia and autism (“ADA”). As part of theclient partner relationship, IBN will generate greater awarenessfor MetAlert through leveraging its investor based distributionnetwork of 5,000+ key syndication outlets, various newsletters, social media channels, wire services via InvestorWire, blogs and other outreach tools. “MetAlert is led by a highlyexperienced management team and operates in a large and growingglobal market in terms of both potential revenue and number ofusers,” said IBN’s Director of Client Solutions Chris Johnson.“We’re excited to customize our comprehensive suite of corporatecommunications solutions for the company as it works to improve thelives of individuals living with Alzheimer’s, dementia and autism,as well as their families and caregivers, with its GPSSmartSoles(R) HUB and portfolio of complementary products andservices.”

To view the full press release, visit https://ibn.fm/gX3oC

MetAlert Inc. (OTC: MLRT) is a pioneer in location sensitive health monitoring devices (estimated $47 billion industry in 2021) and wearable technology products (industry forecast to reach $174 billion by 2030).

With over 20 years of experience and an extensive patent portfolio (30+), MetAlert is a leader for consumers/patients afflicted with Alzheimer’s, dementia, and autism (ADA). This market represents approximately 2.9% of the world’s population (approximately 34 million people in 24 developed countries). Due to specific behaviors (problems with memory, adversity to wearing unknown items, etc.) of consumers/patients in this market segment, traditional products, such as an iPhone or Fitbit, are not a practical solution. This has created a significant market with very few competitors for MetAlert.

MetAlert and its subsidiaries are engaged in designing, developing, manufacturing, distributing, and selling products and services in GPS/BLE wearable technology, personal location, wandering assistive technology, and health data collection and monitoring. The company offers a global end-to-end hardware, software, and connectivity solution, in addition to developing two-way tracking technologies, which seamlessly integrate with consumer products and enterprise applications.

Using its award-winning, patented GPS SmartSole® as a hub for collecting and transmitting data to the cloud in real-time, MetAlert is expanding its value proposition to consumers and increasing its revenue per user (RPU) while creating the largest database of health statistics for ADA consumers/patients. MetAlert generates revenue from product sales, recurring subscriptions, intellectual property (IP) licensing, and professional services. The company has international distributors servicing customers in over 35 countries and is an approved U.S. military government contractor. Its customers include public health authorities and municipalities, emergency and law enforcement, private schools, assisted living facilities, NGOs, small business enterprises, senior care homes and consumers.

The company is headquartered in Los Angeles, California, with a sales office in London, England, and distributors across the globe.

Products

  • GPS SmartSoles® HUB (launched Q4 2022) is a GPS/BLE-equipped insole that allows remote monitoring, data collection, and encrypted data transmission to the cloud.
    • Telehealth (available Q4 2022) allows access remotely to doctors and other health professionals on an as-needed basis. This service will also function as the prescribing doctor once Medicare reimbursement codes are established.
    • Concierge (available Q4 2022) provides 24/7/365 enhanced emergency response that coordinates with all relevant parties to quickly detect false alarms and escalate response as needed.
    • Bluetooth Enabled Devices (available Q1 2023) include third-party devices that collect vitals and other health data and connect with the GPS Smartsoles® HUB.
    • Artificial Intelligence (available Q1 2023) software will evaluate the Teradata of health information identifying trends and respond to preestablished alert thresholds.
  • Take-Along Tracker is a small GPS tracking device – less than three inches long – that works with 4G cellular service and will have the same “HUB” functionality as the GPS Smartsoles®. This versatile and affordable mini tracker boasts super long battery life, with up to 14 days of operation per charge.
  • RoomMate™ is a wall-mounted alert system that detects and alerts caregivers about patient behavior that could lead to falls and injuries. The system features 3D infrared and wall-mounted sensors, eliminating the need for any other physical installation or wearables. RoomMate™ offers patient privacy by design. Images are not stored, but all actions are logged. It’s a unique solution for looking after patients without intruding on their personal space.

Market Outlook

According to Grand View Research (Patient Monitoring Devices Market Size & Share Report, 2030), the global patient monitoring devices market size was valued at $47.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.8% from 2022 to 2030. The expansion of the industry can be attributed to the rise in demand for monitoring devices used to measure, distribute, record, and display a variety of biometric data, including blood pressure, temperature, and blood oxygen saturation level.

The growing number of chronic disorders, such as diabetes, stroke, and kidney disease, are driving the demand for patient monitoring devices. For instance, according to the World Health Organization (WHO), about 422 million people globally have diabetes. Likewise, the number of asthma and chronic obstructive pulmonary disease patients (COPD) is increasing rapidly.

According to the WHO, around 235 million people suffer from asthma. As a result, peak flow meters, which are used to gauge respiration rate, are increasingly used. The market for patient monitoring devices is driven by the simplicity with which it is handled, transported, and remotely accessible. Major market players are engaging in a variety of tactics to expand the industry, including partnerships, cooperation, innovation, launches, and mergers.

During the COVID-19 outbreak, social segregation and quarantining procedures were put into place worldwide. Many people avoided regular hospital visits as a result. Many people now need routine home temperature and oxygen level monitoring to maintain track of their health, thereby demanding monitoring devices at home.

Various government programs are supporting the pandemic outbreak. The FDA has granted Emergency Use Authorizations (EUAs) for a few wearables and patient monitoring devices to improve access to medicines, monitor patients more closely, and lessen the risk of SARS-CoV-2 exposure to medical professionals during the COVID-19 pandemic.

The growing popularity of wearable and remote patient monitoring devices is another factor fueling the market’s expansion. By fusing clinical symptomology with vital indicators, wearable technology helps in the diagnosis of many chronic diseases. Thus, there has been a dramatic rise in the usage of wearable technology to combat COVID-19.

The wearable medical device market is anticipated to reach $174.48 Billion by 2030, expanding at a 27.1% CAGR during the forecast period (2022-2030), according to Market Research Future.

MetAlert identifies the total addressable market for its wearable patient monitoring tech for those with Alzheimer’s, dementia, and autism at more than 34 million potential patients in North America, Europe, South Africa, and Asia.

Management Team

Patrick E. Bertagna is Founder, CEO and Chairman at MetAlert. He began his career in apparel sales in 1983 and was promoted to national sales manager within two years. In 1986, he founded his first company importing apparel from Europe and selling to U.S. retailers from JCPenney to Neiman Marcus. He has founded several technology and apparel companies, including MetAlert in 2002, which he took public in 2008. He attended Cal State University Northridge with a business major and a psychology minor.

Louis Rosenbaum is COO of MetAlert. He co-founded Global Trek Xploration and was an initial investor in MetAlert. He has successfully started companies in multiple industries, including apparel, environmental services, and the music industry, achieving annual revenues in the multi-millions of dollars. He previously was president of Elements, a women’s apparel company, and of Advanced Environmental Services.

Alex McKean is CFO at MetAlert. He is also the CFO of Encore Brands Inc., a position he has held since 2009. He has held positions as Controller and VP of Finance at 24:7 Film and InternetStudios.com, Director of FP&A/SVP at Franchise Mortgage Acceptance Company, Corporate Accounting Manager/Treasurer of Polygram Filmed Entertainment and Assistant Treasurer/Controller for State Street Bank. He holds an International MBA from Thunderbird School of Global Management and undergraduate degrees in business and political science from Trinity University.

MetAlert Inc. (OTC: MLRT), closed Tuesday's trading session at $0.46, even for the day, on 6,001 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.06/$1.00.

Recent News

Advanced Container Technologies Inc. (OTC: ACTX)

The QualityStocks Daily Newsletter would like to spotlight Advanced Container Technologies Inc. (OTC: ACTX).

Cannabis reform activists in the state of Ohio are hoping to get arecreational cannabis legalization bill on the November 2023ballot. Earlier this year, the campaign behind a legalizationmeasure announced that the bill would not be on the 2022 ballot but that there was achance of getting the measure on the subsequent year’s ballot.

The Coalition to Regulate Marijuana Like Alcohol had filed a complaint for declaratory judgment in April to ensure that the measure made it onto last month’sballot. The suit was unsuccessful, however, and the coalitionreached an agreement with legislative leaders and the secretary ofstate which put their legislation on track to appear on next year’sballot.

Tom Haren from the coalition said at the time that the most important thing was that Ohio voterswould still have the chance to decide on recreational cannabislegalization even if it wasn’t during the November 2022 ballot. Headded that the campaign “wasn’t going anywhere” and that supporterswere resolute in their goal to legalize adult-use cannabis in thestate.

The onward march of cannabis legalization brings opportunities notonly for companies that will directly deal with plant-touchingproducts but also for others such as Advanced Container Technologies Inc. (OTC: ACTX) that are tangentially linked to the industry.

Advanced Container Technologies Inc. (OTC: ACTX) is in the business of selling and distributing self-contained, automated, indoor “micro-farms” called Grow Pods, along with related equipment and supplies. Additionally, the company designs and sells patented proprietary medical-grade plastic containers, known as the Medtainer®, that store and grind pharmaceuticals, herbs, teas and other solids or liquids.

ACTX is the leading distributor of Grow Pods. With a controlled environment, food and herbs can be grown without pesticides, harmful chemicals or risk of pathogen contamination, and with low energy consumption. Restaurants, grocery stores, non-profits, MSOs and entrepreneurs can use Grow Pods to ensure a fresh supply of ultra-clean produce year-round.

The company entered the Grow Pod business in October 2020 with its acquisition of all shares of Advanced Container Technologies Inc., a California corporation. As of February 28, 2022, ACTX is exploring the acquisition of the assets and the assumption of some or all of the liabilities of GP Solutions Inc., the developer and manufacturer of Grow Pods, for which ACTX is currently the sole U.S. distributor.

Because Grow Pods can be located almost anywhere, produce can be grown closer to the point of consumption and harvested at its peak, providing nutritious fruits and vegetables where needed. Indoor micro-farms, utilizing a practice known as vertical farming, have attracted the attention of governments and universities, which are now promoting vertical farming as a way to combat food insecurity and inequities.

The United States Department of Agriculture (USDA) has stated that vertical farming “is no longer a futuristic concept.” The department is enthusiastic about vertical farming, particularly those utilizing repurposed shipping containers, such as Grow Pods. Arizona State University reports that vertical farming reduces water use by 90 percent compared to conventional farming but produces 10 times the crop yield.

Products

Grow Pods

One of the company’s main business units is focused on selling advanced, self-contained hydroponic containers called Grow Pods. These unique and innovative automated systems are essentially micro-farms that can be placed virtually anywhere and, with their controlled and specially filtered environment, allow cultivation of a wide variety of crops, 365 days a year. The Grow Pod controlled environment offers major advantages for the production of high-value crops. The ability to grow year-round and the ability to cultivate in a smaller footprint using less water and power are some of the primary advantages of the system. Grow Pods offer constant temperature, humidity and airflow control, as well as automated watering and lighting schedules for optimal growth and minimal labor requirements, regardless of crop.

Containers

ACTX meets the needs of the pharmaceutical and medical markets, including the cannabis and hemp industries, with patented packaging systems. The company designs, customizes, brands and sells proprietary medical grade plastic containers that can store pharmaceuticals, herbs, teas and other solids or liquids, with a special built-in feature that can grind solids and shred herbs. The company’s flagship container product is the patented Medtainer®, a child resistant, medical-grade herb container and grinder that is water-tight, air-tight and smell proof. Packaging in the cannabis industry is critical, with numerous stringent regulations about how cannabis products must be packaged and labeled. ACTX also offers custom-branded, compliant vacuum seal bags and other retail container solutions.

Equipment and Supplies

ACTX markets and sells two principal products: Grow Pods, which are specially modified insulated shipping containers manufactured by GP Solutions Inc., in which plants, herbs and spices may be grown hydroponically in a controlled environment, and Medtainers®, which may be used to store pharmaceuticals, herbs, teas and other solids or liquids and can grind solids and shred herbs. The company also markets and sells various products related to Grow Pods and the Medtainer®, as well as providing private labeling and branding services for purchasers of Medtainers® and certain related products.

GP Solutions manufactures and sells other products, such as humidity controllers and LED lighting systems for vertical farming. The company’s specially designed lighting panels are programmed to emit the exact wavelength of light that each crop requires. The system has a daybreak-to-nightfall feature that gives plants the proper chromatic signals to grow rapidly and fruitfully. High efficiency LED light strips supply the crops with a red and blue light spectrum required for photosynthesis in the spectrum that plants need most.

Market Overview

The global vertical farming market is expected to reach $33.02 billion by 2030, according to a new report by Grand View Research. The market is forecast to expand at a CAGR of 25.5 percent from 2022 to 2030, according to Grand View. Escalating production of biopharmaceutical products, including cannabis, is anticipated to drive the market. The building-based segment of the market is expected to register a significant CAGR of 27.8 percent over the projected period. In addition, the climate control segment is expected to see high growth.

The global cannabis packaging market is expected to reach $14.34 billion by 2028, according to analysis by Reports and Data. The analysis forecasts 1,700 percent growth in cannabis users by the end of 2026, with packaging likely observing a whopping 26.42 percent growth in the forecast period. There are significant barriers to entry in the cannabis packaging market, giving an advantage to companies already established in the sector. These barriers include developing a thorough knowledge of the myriad regulations that govern cannabis packaging (which differ in each state), and child-resistance requirements.

Management Team

Douglas P. Heldoorn is the Founder and Chairman of Advanced Container Technologies Inc. He also holds the positions of President, CEO and COO at the company. Mr. Heldoorn has served on the Board of Directors since its inception in 2013. He has also previously held the position of Executive General Manager at Nissan Motor Corp.

Jeffory A. Carlson is CFO and Treasurer of ACTX. Mr. Carlson has also served as the company’s Corporate Controller since 2014.

Advanced Container Technologies Inc. (OTC: ACTX), closed Tuesday's trading session at $0.3, even for the day, on 348 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.2005/$1.42.

Recent News

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV)

The QualityStocks Daily Newsletter would like to spotlight BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV).

As mobile phones, social media and apps have taken center stage inour lives, several experts have become increasingly worried about the amount of time the average person spends looking atscreens. On average, people around the world spend nearly sevenhours daily on their screens, with the average American spending anaverage of seven hours and four minutes every day on their screens. Gen Z, the generation that grew up withthe internet, spends up to nine hours per day looking at screens.But while studies show that too much screen time can have negative effects on adolescents and children, recent research reveals that there are some instances where screen time can bebeneficial. A study, which was published in “American Academy of Pediatrics,” suggests that screen time can help teenagers who sustainedconcussions recover from their head injuries. Traditionally,experts recommend refraining from strenuous physical activity after a concussion and resting for a few days to speed uprecovery. Autoimmune illnesses such as asthma are also ticking upin the pediatric and general population, and novel therapeutics aresorely needed to address this growing need. Entities such as BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) have projects in the pipeline geared at meeting this need.

 

BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotech company focused on developing, manufacturing andcommercializing innovative immunotherapeutic products primarily forthe treatment of infectious and autoimmune diseases, has appointeda new scientific advisory board member: Dr. Matthias Dobbelstein,director of the Institute of Molecular Oncology at the UniversityMedical Center Göttingen in Germany since 2005 and also anassociate member of the Max Planck Institute for MultidisciplinarySciences (“MPI-NAT”). During his career, Dobbelstein has amassedimpressive experience, particularly with his research, which hasfocused on principles of infections and cancer. He has studied theapplication of anticancer drugs as antivirals and has also workedwith alpaca-derived NanoAbs, or nanosized antibodies known asnanobodies and VHH antibodies, as therapeutics. Dobbelstein and Dr.Dirk Görlich have provided research that serves as the scientificbasis of BiondVax’s exclusive license for development andcommercialization of an innovative, self-administered, inhaledNanoAb for the treatment of COVID-19, an approach that indicatedsignificantly milder illness and faster recovery in a recent study.Dobbelstein and Görlich are collaborating with BiondVax to worktoward the discovery, characterization and cloning of additionalNanoAbs for the treatment of autoimmune diseases such as psoriasis,psoriatic arthritis, asthma and macular degeneration. “We have beenenjoying productive scientific cooperation with ProfessorDobbelstein over the past year through our collaboration to develophis and Professor Görlich’s translational NanoAb research into adrug candidate for the treatment of COVID-19, which is currentlybeing tested in a preclinical study,” said BiondVax Pharmaceuticalschief science officer Dr. Tamar Ben-Yedidia in the press release.“On behalf of BiondVax’s executive team, I am pleased to welcomeMatthias to our SAB and am confident his deep scientific andclinical knowledge will meaningfully contribute to further buildingBiondVax into an innovative multi-asset pharmaceutical company.” Toview the full press releases, visit https://ibn.fm/vg7na and https://ibn.fm/L3JvA.

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) is a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses.

In collaboration with the prestigious Max Planck Institute for Multidisciplinary Sciences (MPG) and the University Medical Center Göttingen (UMG), both in Germany, BiondVax is developing a pipeline of innovative nanosized antibody (NanoAb) therapies addressing diseases underserved by current treatments and with large and growing markets, such as COVID-19, asthma and psoriasis.

NanoAbs, also known as VHH-antibodies or Nanobodies, are alpaca-derived nanosized antibodies that exhibit multiple significant competitive advantages over existing antibody therapies, including stability at high temperatures, superior binding affinity, more effective and convenient routes of administration and efficient production. BiondVax is uniquely positioned to advance nanosized antibody innovation from R&D through commercialization.

The company’s highly experienced and successful pharmaceutical industry leadership team includes former senior executives from Novartis, GSK and Bristol-Myers Squibb.

Since its founding, BiondVax has executed eight clinical trials, including a seven-country, 12,400-participant Phase 3 trial of a prior influenza vaccine candidate, and it built, owns and operates a 20,000 sq. ft. state-of-the-art GMP biologics manufacturing facility housing its laboratories, production facilities and offices.

Lead Candidate: Inhaled COVID-19 NanoAb

In December 2021, BiondVax signed definitive agreements with the Max Planck Society – parent organization of the Max Planck Institute for Multidisciplinary Sciences– and the UMG to enter a strategic collaboration for the development and commercialization of innovative COVID-19 NanoAbs.

The company is planning a rapid development path that leverages its expertise and capabilities in biological drug development and manufacturing. BiondVax anticipates preclinical proof-of-concept results for an inhaled COVID-19 NanoAb by the end of 2022, with initial Phase 1/2a human clinical trial results expected in 2023.

The intended inhaled mechanism of delivery of BiondVax’s COVID-19 NanoAb formulation may serve as a significant differentiator when compared to approved monoclonal antibodies, which are injected. Inhaled delivery has shown to be cheaper, more convenient and likely safer for patients and providers.

NanoAb Pipeline: Psoriasis, Asthma and More

The COVID-19 NanoAb development agreement is part of a broader five-year research collaboration agreement signed in March 2022 covering discovery, development and commercialization of NanoAbs for several other disease indications with large market medical needs, including asthma, psoriasis, macular degeneration and psoriatic arthritis.

BiondVax has an exclusive worldwide license for development and commercialization of COVID-19 NanoAbs and exclusive options for similar worldwide licenses for NanoAbs for the above mentioned additional large market disorders currently underserved by approved therapeutic antibodies.

Academic research teams from MPG and UMG have verified strong affinity by the new NanoAbs to their biological target molecules and high thermostability. They have also demonstrated strong neutralization by several NanoAb candidates of their respective target molecules. Neutralization studies of the other NanoAbs are expected to begin later in 2022.

Based on the promising results, BiondVax will focus development efforts beginning with the following NanoAbs:

  • NanoAbs targeting IL-17 as drug candidates for the potential treatment of psoriasis and psoriatic arthritis
  • NanoAbs targeting IL-13 and NanoAbs targeting TSLP as drug candidates for the potential treatment of asthma

These are conditions for which the antibody target is validated by existing treatments and the mechanism of action is well understood. Both represent large medical needs and growing markets. BiondVax anticipates preclinical proof-of-concept for at least one of these NanoAbs in 2023. This is in addition to the aforementioned human clinical Phase 1/2a for the inhaled COVID-19 NanoAb therapy, which is also anticipated in 2023.

Market Opportunity

COVID-19 treatment, target of the company’s lead NanoAb therapy candidate, had an estimated market size of $22 billion in 2021.

Future BiondVax drug candidates will target conditions with large markets growing at attractive CAGRs.

The global asthma treatment market was valued at $18.08 billion in 2019 and is projected to reach $26.01 billion by 2027, exhibiting a CAGR of 4.5% during the forecast period, according to Fortune Business Insights. The research firm predicts that the global psoriasis treatment market will grow from $26.37 billion in 2022 to $47.24 billion by 2029, exhibiting a CAGR of 8.7% over the forecast period.

Management Team

Amir Reichman is BiondVax’s CEO. He previously was Head of Global Vaccines Engineering Core Technologies at GSK Vaccines in Belgium. Prior to that, he held leadership roles at Novartis Vaccines’ Global Vaccines Supply Chain Management organization. He was the first employee of NeuroDerm Ltd., a company focused on transdermal drug delivery, and served as Chief Engineer and Senior Scientist until his departure in 2009. He earned a M.Sc. in Biotechnology Engineering from Ben-Gurion University and an MBA in Finance and Health Care Management from the University of Pennsylvania’s Wharton School.

Tamar Ben-Yedidia, Ph.D., is Chief Science Officer at BiondVax. She has more than 30 years of experience in immunology, with specific expertise in the development of vaccines. She began her career with Biotechnology General Ltd., working on development of a recombinant Hepatitis-B vaccine. She later joined the Weizmann Institute of Science, working on the design of a peptide-based vaccine against several pathogens. She is widely published, with numerous refereed articles and invited reviews in various scientific journals. She received her Ph.D. from the Weizmann Institute.

Elad Mark is COO at BiondVax. He has over 15 years of biotechnology industry experience encompassing diverse project stages including feasibility studies, conceptual and detailed design, commissioning, qualification and process validation. Prior to joining BiondVax, he led Novartis’s $800 million investment in a biologics facility in Singapore. With Biopharmax and Antero, both global pharmaceutical engineering companies, he successfully led projects in Israel, China and Singapore. He holds a BSc. in Engineering from the Afeka Tel Aviv Academic College of Engineering and an MBA from the Open University of Israel.

Uri Ben-Or is CFO at BiondVax. He has served as CFO with public life science companies traded on the TASE, OTC and Nasdaq. Ben-Or provides his services to BiondVax through CFO Direct, a company he founded and for which he serves as CEO. He served as the VP of Finance of Glycominds, a leading biotechnology company, and as CFO of a spin-off from Telrad Networks. He also served as a Corporate Controller at Menorah Capital Markets and as an Auditor at PWC. He holds a B.A. in Business from the College of Administration, an MBA from Bar-Ilan University, and is a CPA.

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), closed Tuesday's trading session at $9.81, off by 1.072%, on 4,537 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $5.335/$34.90.

Recent News

Knightscope, Inc. (NASDAQ: KSCP)

The QualityStocks Daily Newsletter would like to spotlight Knightscope, Inc. (NASDAQ: KSCP).

Knightscope, Inc. (NASDAQ: KSCP) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company forprivate and public entities. To view the full publication, “TheRise of the Robots — Already Here, More Are Coming,” please visit: https://nnw.fm/YPxvg.Although some people may be surprised, today’s world is full ofrobots. While these electro-mechanical devices may not be in theform of a cyborg RoboCop, they’re already serving people incountless ways. Industrial robots are a primary application today,with the world becoming accustomed to, and even expecting,life-altering technologies as robots shuttle people around, performsurgeries, keep communities safe, and much more.

Knightscope, Inc. (NASDAQ: KSCP), founded in 2013 and based in Mountain View, California, is a leader in the development of autonomous security capabilities targeting to disrupt the $500 billion security industry. Knightscope’s technology uniquely combines self-driving technology, robotics, artificial intelligence and electric vehicles.

Knightscope designs and builds Autonomous Security Robots (ASRs) that provide 24/7/365 security to the places you live, work, visit and study. The company’s client list covers public institutions and commercial business operations, including multiple Fortune 1000 companies to date. These ASRs have been proven to enhance safety at hospitals, logistics facilities, manufacturing plants, schools and corporations. ASRs act as highly cost-effective complementary systems to traditional security and law enforcement officials, providing an additional advantage by continuing to offer uninterrupted patrolling capabilities across the country.

The company’s ASRs have assisted in the arrest of suspects involved in crimes ranging from armed robbery to hit-and-runs. Their machine-embedded thermal scanning capability even aided in preventing the breakout of a major fire. You can learn more about the crime fighting wins at www.knightscope.com/crime

The company has achieved several milestones since its creation in 2013, including:

  • Establishing itself in a 15,000-square-foot facility located in Mountain View, California, in the heart of Silicon Valley, where Knightscope designs, engineers and builds its technology (Made in the USA)
  • Operating for more than 1 million hours in the field and securing contracts across five time zones, from Hawaii to Rhode Island
  • Raising over $100 million since inception to build its technology from scratch and generating over $13 million in lifetime revenue, validating both the market opportunity and the technology

Growth Capital & Proposed Nasdaq Listing

With backing from more than 28,000 investors and four major corporations and over $100 million raised since inception, Knightscope is poised to be an industry leader in the future of public safety and security.

On December 1, 2021, Knightscope announced the commencement of an offering of up to $40 million of its Class A common stock, with shares to be listed immediately following closing on the Nasdaq Global Market under the ticker symbol ‘KSCP’. The offering is for up to 4 million shares priced at $10 per share. Learn more at www.knightscope.com/investors

Company Mission – Reimagining Public Safety

Knightscope’s long-term vision has an eye on the greater good. The company’s mission is to make the United States of America the safest nation in the world while supporting the 2+ million law enforcement and security professionals across the country.

Crime has an estimated negative economic impact in excess of $2 trillion annually. As crime is reduced, positive impacts will likely be realized across several aspects of society, including housing, financial markets, insurance, municipal budgets, local business and safety in general.

Knightscope CEO William Santana Li was interviewed by Kevin O’Leary, more commonly known as Shark Tank’s Mr. Wonderful. When asked to explain how the benefits provided by the ASRs outrank a human doing the same job, Li said, “First, just the simple presence of a physical deterrent causes criminal behavior to change. Second, the machines are self-driving cars that patrol all around and recharge themselves. They also generate 90 terabytes of data per year. No human would ever be able to process that. The robots are intended to be eyes and ears for the humans, not a one-to-one replacement.”

The Knightscope solution to reduce crime combines the physical presence of ASRs, sometimes referred to as proprietary Autonomous Data Machines, with real-time onsite data collection and analysis. The ASRs are fitted with eye-level 360° cameras, thermal scanning, public address announcements and various other features that work in tandem with humans to provide law enforcement officers and security guards unprecedented situational awareness.

Those 90 terabytes of data are then formatted in a useable way, so law enforcement can leverage that information and execute their responsibilities more effectively.

Public Safety Innovation

The company’s recurring revenue business model is set up to mimic the recurring societal problem of crime, and it takes into consideration the fact that innovation in the security and public safety industry has been stagnant for decades. Because the traditional practices of the sector have remained unchanged for years, automation has potential to drive substantial cost savings – and significant improvement in capabilities.

Human security guards are one of both the largest expenses and the largest liabilities for companies. Knightscope’s robots are offered at an effective price of $3 to $9 per hour, compared with approximately $85 for an armed off-duty law enforcement officer and $15 to $35 for an unarmed security guard.

This innovation has the potential to drive considerable cost savings. Based on these estimates, manufacturing costs can be recovered as soon as the first year of operation.

Product Offerings

The company has nine patents and a framework of unique intellectual property. Knightscope currently offers a K1 stationary machine, a K3 indoor machine and a K5 outdoor machine. A K7 multi-terrain four-wheel version is in development.

The ASRs autonomously patrol client sites without the need for remote control, providing a visible, force multiplying, physical security presence to help protect assets, monitor changes in the area and deter crime. The data is accessible through the Knightscope Security Operations Center (KSOC), an intuitive, browser-based interface that enables security professionals to review events generated by the ASRs providing effectively ‘mobile smart eyes and ears’. Learn more at www.knightscope.com/ksoc

The ASRs and the related technologies were developed ground up by the company and are Made in the USA.

The Robot Roadshow

Knightscope has created the ultimate hybrid physical and virtual event, bringing its Autonomous Security Robot technologies to cities across the country for interactive and in-person demonstrations.

Each roadshow landing is hosted virtually by a Knightscope expert, and visitors can interact directly with each of the company’s ASRs and see the Knightscope Security Operations Center (KSOC) user interface in action. Learn more at www.knightscope.com/roadshow

Management Team

Chief Executive Officer William Santana Li is a veteran entrepreneur, a former executive at Ford Motor Company and the founder of GreenLeaf, a company that grew to be the world’s second-largest automotive recycler and is now part of LKQ Corporation (NASDAQ: LKQ).

Chief Client Officer Stacy Dean Stephens brings his experience as a former Dallas law enforcement officer, as well as his skills as a seasoned entrepreneur, to assist on the client acquisition side.

Chief Intelligence Officer Mercedes Soria is an award-winning technologist and former Deloitte software engineer.

Chief Design Officer Aaron Lehnhardt brings over two decades of two- and three-dimensional product and industrial design in modeling and VR to the table, on top of his experience as a senior designer at Ford Motor Company.

Chief Financial Officer Mallorie Burke is a seasoned financial executive and strategic advisor for both private and publicly traded technology companies with a successful track record of mergers & acquisitions, corporate growth and exit strategies, including public listings.

General Counsel Peter Weinberg leverages 30 years of diverse corporate counsel experience, spanning from startups to well-established companies, private and public. He has significant experience training personnel at all levels in critical areas to improve corporate compliance and productivity.

Knightscope, Inc. (NASDAQ: KSCP), closed Tuesday's trading session at $2.09, off by 2.7907%, on 167,289 volume. The average volume for the last 3 months is 167,289 and the stock's 52-week low/high is $2.07/$27.50.

Recent News

Cybin Inc. (NEO: CYBN) (OTC: CYBN)

The QualityStocks Daily Newsletter would like to spotlight Cybin Inc. (NEO: CYBN) (NYSE American: CYBN).

Cybin Inc. (NEO:CYBN) (NYSE American: CYBN) ( Cybin or the Company ), abiopharmaceutical company focused on progressing Psychedelics toTherapeutics ® , today announced that the Companypresented two posters on its deuterated psilocybin analog, CYB003,at the American College of Neuropsychopharmacology (“ACNP”) annualmeeting taking place December 4-7, 2022, in Phoenix, Arizona. Thedata presented, including new pharmacokinetics (“PK”) findings,further strengthen the therapeutic profile of CYB003 as a noveltreatment for major depressive disorder (“MDD”).

“These new findings demonstrate the unique PK properties of CYB003compared with classical psilocybin and further supports our ongoingfirst-in-human Phase 1/2a clinical trial evaluating CYB003 for thetreatment of MDD,” said Amir Inamdar, MBBS, DNB (Psych), MFPM,Cybin’s Chief Medical Officer. “We were honored to present our dataat ACNP amongst leading scientists and academics inneuropsychopharmacology.”

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) is a Canada-based life sciences company focused on the pharmaceutical development of psychedelic products, as well as the functional mushroom market.

The early-stage company boasts an experienced management team featuring industry veterans from pharmaceutical and consumer product backgrounds who have run multiple clinical trials and collectively helped facilitate billions of dollars in product revenues. The team is dedicated to the development of products and protocols within the psychedelic, pharmaceutical and nutraceutical industries.

In particular, Cybin aims to further build upon and expand its intellectual property (IP) portfolio, which is structured around unique psilocybin delivery mechanisms that target a number of different therapeutic indications. In addition, the company has dedicated itself toward furthering its research and IP within the fields of synthetic compounds, extraction methods, the isolation of chemical compounds, new drug formulations and protocol regimes.

Serenity Life Sciences & Natures Journey Inc.

The company’s business model is centered around its two core subsidiaries, Serenity Life Sciences and Natures Journey Inc., which comprise Cybin’s two-pronged approach toward delivering fungi-derived psychedelic and medicinal products.

Serenity Life Sciences is focused on furthering research and development of psilocybin-based medications. Psilocybin is found in certain species of mushrooms and is a non-habit forming, naturally occurring psychedelic compound. Research into psilocybin has shown positive results for the treatment of depression, anxiety, PTSD, addiction, eating disorders, ADHD and other indications.

Natures Journey Inc. operates the Journey brand, which specializes in developing proprietary medicinal mushroom products that target and promote mental wellness, immune boosting detoxification and overall general health and wellbeing.

Partnership with the Toronto Centre for Psychedelic Science (TCPS)

Staying true to its axiom of being a research-first medicinal mushroom life sciences company, Cybin recently announced its entry into a strategic partnership with the Toronto Centre for Psychedelic Science (TCPS), with the goal of furthering its ongoing psilocybin research efforts and expanding Cybin’s psilocybin IP portfolio (http://nnw.fm/9EUkI).

“While there is evidence to support psilocybin as a treatment for certain indications, the Toronto Centre for Psychedelic Science is taking a clinical approach to prove or disprove the safety and efficacy of psilocybin-based microdosing through an open science approach,” Paul Glavine, CEO of Cybin, stated in a news release.

“We are excited to join forces with Cybin and to offer our expertise. A number of firms had approached TCPS, but Cybin demonstrated a superior commitment to high-quality research and integrity in product development. Our high standards for scientific rigor and transparency will find a fitting home within the culture Cybin is cultivating in Canada and abroad,” Thomas Anderson, co-founder of the Toronto Centre for Psychedelic Science, added.

Journey’s Product Monetization & Market Potential for Nutraceutical Supplements

Although Cybin is at the forefront of companies seeking to conduct clinical trials aimed at gaining regulatory approval for psilocybin and other psychedelic products, the company has also placed a great deal of emphasis on generating meaningful revenue from its very outset.

Cybin’s Journey brand has is launching a range of supplements comprised of popular fungi-derived ingredients such as Reishi, Lion’s Mane and Cordyceps. Purported to aid focus and concentration while promoting neurogenesis, Journey’s range of nutraceutical products provides Cybin with a crucial foothold within the non-psychedelic legal supplement market, which is valued at over $25 billion globally and growing at a 9% year-over-year rate.

Pharmaceutical Psychedelics

In addition to the company’s range of non-psychedelic supplements, Cybin has plans to carry out a clinical trial with a new delivery system for its psilocybin-based medications later this year. Ultimately, the company aims to enter into technology transfer agreements with global pharmaceutical companies after phase 1 & phase 2 clinical trials are complete in order to accelerate regulatory approvals in major indications in global markets with entire lifecycle product management.

With products such as psilocybin truffles already legal in nations such as the Netherlands, Jamaica and Bulgaria, Cybin has positioned itself to capitalize on an eventual legalization of psychedelic mushroom-derived products in the future. Working within a regulatory environment with strong similarities to that which dealt with cannabis prior to the industry’s eventual legalization by the Canadian government in 2018, Cybin is laying the groundwork for the moment pharmaceutical psychedelics gain acceptance in North America and abroad.

Amalgamation Agreement and Financing

Cybin recently announced its entry into an amalgamation agreement dated June 26, 2020, with Clarmin Explorations Inc. (TSX.V: CX) and 2762898 Ontario Inc., a wholly owned subsidiary of Clarmin (http://nnw.fm/w04LH). Completion of the transactions contemplated in the amalgamation agreement will result in the reverse takeover of Clarmin by Cybin.

In connection with the proposed transaction, Cybin plans to complete a “best-efforts” brokered private placement of subscription receipts of Cybin, with a syndicate of agents co-led by Stifel Nicolaus Canada Inc. (Stifel GMP) and Eight Capital, to raise a minimum of C$14 million ($10 million) and a maximum of C$21 million ($15 million), with a 15% agents’ option.

To date, Cybin has raised approximately C$10,400,000 through an initial financing round and its series A financing round.

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), closed Tuesday's trading session at $0.3373, off by 4.5557%, on 1,164,971 volume. The average volume for the last 3 months is 1.149M and the stock's 52-week low/high is $0.33/$1.43.

Recent News

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF)

The QualityStocks Daily Newsletter would like to spotlight Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF).

 

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) is the leading psychedelic wellness platform, committed to bringing science-backed benefits to all and reframing the psychedelic conversation. The company owns and operates an umbrella of related businesses, including trusted media and e-commerce platforms like Reality Sandwich and Delic Radio; Delic Labs, the only licensed entity by Health Canada to exclusively focus on research and development of psilocybin vaporization technology; Meet Delic, the premiere psychedelic wellness event; and Ketamine Infusion Centers, one of the largest ketamine clinics in the country.

Delic is backed by a team of industry and cannabis veterans and a diverse network, whose mission is to provide education, research, high-quality products, and treatment options to the masses. Its founders helped build the multi-billion-dollar cannabis industry and aim to do the same in psychedelics as it follows a similar path toward legalization. In its quest to advance the new psychedelic renaissance upon us, Delic has become the pioneer in its field, creating an ecosystem of opportunities by investing in cutting-edge ideas.

The Vancouver-based company was formed in 2019 to address the growing interest in psychedelic wellness backed by science. Delic was the ‎first psychedelic umbrella platform. It is currently a trusted source for those interested in ‎psychedelic culture, education, treatments, and more.

While other emerging companies focus on patent medicine and big pharma for substances limited by government regulation, Delic is blazing a unique trail. It identifies ancillary and fully legal opportunities like IP, new media, live events, ketamine clinics (with the ability to offer additional psychedelic treatments once legalized, and large-scale production and brings them under its big tent of resources and reach.

The Big Problems Delic Is Addressing

  • Fifty percent of Americans will meet the criteria for a mental health condition sometime in their lifetime. The FDA has approved psilocybin therapy as a breakthrough therapy for depression.
  • Every 40 seconds, someone in the world commits suicide. Ketamine has been shown to decrease thoughts of suicide significantly. In 2019, the FDA approved esketamine as a fast-acting antidepressant.
  • Traditional palliative care methods do not eradicate end-of-life (EOL) anxiety. LSD and psilocybin have been shown to reduce EOL anxiety for terminally ill patients. Eighty percent of terminally ill patients with psilocybin sessions experienced significant reductions in depression and anxiety.
  • Approximately 50 million people in the U.S. are addicted to some tobacco product. Research shows that psilocybin is helping people quit smoking.

The Delic Ecosystem

The Delic Ecosystem covers three main areas: media, health, and science. The media focus is educating and motivating the masses through a variety of digital platforms, like Delic’s Reality Sandwich digital magazine, a free public education platform providing psychedelic guides, news and ‎culture (1.4+ million page views in 2020 and 54k social media followers across all platforms); Meet Delic, the first-ever psychedelic wellness summit and the premier psychedelic wellness event based in Las Vegas (over 2,000 live attendees and 5,000+ email subscribers); and Delic Radio (over 43 episodes and 100k total streams). Delic has also been featured in numerous media outlets like Forbes, NBC News, The Joe Rogan Experience, Daily Beast, High Times, and The Dr. Drew Podcast.

The focus of Delic’s health operations is the most accessible psychedelic treatments that can help billions of people live happier lives. Delic does this through one of the largest ketamine clinic chains in the country, Ketamine Infusion Centers (KICs), a limited liability corporation formed under the laws of Arizona that runs three ketamine clinics located in Bakersfield, California, and Phoenix, Arizona. Its management team has over 15 years of experience in the clinic and medical space, scaling and operating over 20 clinics, with a plan to open 10 more clinics in the next 18 months. Together, these clinics have overseen 4,000+ treatments delivered to date.

The focus of Delic’s science operations is developing IP and advanced extraction and testing facilities that are the backbone of the legal market. Delic carries this out through Delic Labs, a licensed cannabis and psilocybin research laboratory based in Vancouver. It’s the only entity licensed by Health Canada to exclusively focus on research and development of psilocybin vaporization technology.

Founded by award-winning chemists, Delic Labs focuses on extraction optimization, analytical testing, and chemical process development to advance the cannabis and psilocybin industries. Health Canada gave it a Section 56 Exemption to work with psilocybin compounds, allowing the company to possess and research these products for development and quality control before they hit the market.

Latest Acquisition – Homestead Book Company

On March 4, 2021, Delic announced its acquisition of Seattle-based Homestead Book Company. Homestead is a legacy counterculture distributor of psychedelic media. It’s also the creator of one of the first self-contained psilocybin mushroom grow kits.

The acquisition of Homestead is an exciting one, as it shows how Delic is increasing accessibility to this nascent industry within regulated jurisdictions. Homestead has sold tens of thousands of mushroom kits globally and was one of the earliest distributors for High Times and many other counterculture publications.

The Homestead acquisition allows Delic to increase its product offerings on its website, Reality Sandwich, which recently hit a record for average monthly traffic of over 200,000 unique visitors and over 2.6 million active readers in 2020.

Market Outlook

The psychedelic renaissance is here. Just in time to help address the global mental health crises, plant medicines have the potential to help billions of people live happier lives. Thanks to university-led and FDA-approved studies, North America is leading the way in advancing an industry as psychedelics are becoming accepted globally for therapeutic, medical, and recreational use. Here are some statistics:

  • 32 million people in the U.S. have used psychedelics at least once
  • 17% of all American adults between 21 and 64 have used psychedelics at least once
  • $500 billion is spent in the U.S. every year on prescription drugs
  • $238 billion is spent in the U.S. every year on mental health treatments and ancillary services
  • The anxiety disorder and depression treatment market is estimated at $16 billion
  • $187.8 billion was spent in 2013 on mental health and substance abuse disorders

Management Team

Delic Co-Founder and CCO Jackee Stang was an executive at High Times, a leading counterculture publication that became the voice for the cannabis industry. The monthly magazine had a circulation of over 500,000 copies per issue. Its website attracted 500,000 to five million users each month by 2014.

Likewise, company Co-Founder and CEO Matt Stang was a previous owner and operator of High Times, a position from which he played an instrumental in legalizing cannabis in multiple states and launched the Cannabis Cup in America. After interacting with the cannabis community for two decades, he helped found Delic in 2019 as one of the first psychedelic corporations. He shapes the company’s vision and path using his expertise in branding, marketing, business development, and product viability.

Delic’s VP of Business Development, John Coleman, Ph.D., is a former president of Anandia Labs, a biotech company focused on genetics and analytics. Having experience in both science and business, Dr. Coleman is well-equipped to lead Delic’s business development efforts as it strives to enter new vertical markets.

Zak Garcia is the company’s Chief Marketing Officer. He was the former CMO of Bulletproof Inc., maker of the well-known Bulletproof Coffee brand. Mr. Garcia is a marketing and leadership strategist who helped grow Bulletproof Coffee to over $250 million in revenue.

Delic Holdings Corp. (DELCF), closed Tuesday's trading session at $0.02924, off by 0.544218%, on 9,162 volume. The average volume for the last 3 months is 9,162 and the stock's 52-week low/high is $0.022/$0.1597.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.